Fordham Law School

FLASH: The Fordham Law Archive of Scholarship and History
Faculty Scholarship
1993

Antitrust Liability for Collective Speech: Medical Society Practice
Standards
Mark R. Patterson
Fordham University School of Law, mpatterson@law.fordham.edu

Follow this and additional works at: https://ir.lawnet.fordham.edu/faculty_scholarship
Part of the Law Commons

Recommended Citation
Mark R. Patterson, Antitrust Liability for Collective Speech: Medical Society Practice Standards, 27
Antitrust L. J. 51 (1993)
Available at: https://ir.lawnet.fordham.edu/faculty_scholarship/778

This Article is brought to you for free and open access by FLASH: The Fordham Law Archive of Scholarship and
History. It has been accepted for inclusion in Faculty Scholarship by an authorized administrator of FLASH: The
Fordham Law Archive of Scholarship and History. For more information, please contact
tmelnick@law.fordham.edu.

Antitrust Liability for Collective Speech:
Medical Society Practice Standards
MARK R. PATTERSON*

While it would probably be excessive to say that the fox is
guarding the chicken coop, it is undeniable that a great many
critical judgments in [the medical] field are being made by persons
with a direct economic stake in particular outcomes .... The
vast majority of physicians and their organizations sincerely
believe that they are acting in the public interest. Yet this is
not enough. To be genuinely well served, the public must have
assurance that those in control are responsive to consumer needs.
1
-Former F.T.C. Chairman Michael Pertschuk
INTRODUCTION
In

the provision of professional services, 2 as in other commerci-

al arrangements, the antitrust laws are intended to preserve competi* The Ohio State University, B.S.E.E., 1978, M.S. 1980; Stanford Law School,
J.D., 1991. The author practices in Boston, Massachusetts. Currently, however, he is
serving as law clerk to Justice John M. Greaney of the Supreme Judicial Court of
Massachusetts. The views expressed in this Article are those of the author alone.
1. Statement prepared for presentation to the Subcommittee on Health and Scientific Research of the United States Senate, Oct. 10, 1977, quoted in American Medical
Ass'n v. F.T.C., 638 F.2d 443, 455 (2d Cir. 1980) (Mansfield, J., dissenting), aff'd by
an equally divided Court per curiam, 455 U.S. 676 (1982).
2. This Article focuses particularly on medical services. In part, that is because
ifresponds to several recent decisions regarding standard-setting in medical societies. But
it is also because medical standard-setting remains a largely private activity, in contrast
to, for example, the same process in the legal profession, where standards of the American
Bar Association are often adopted by state supreme courts. See, e.g., MAss. Sup. Jun.
Cr. R. 3:07 (setting out "canons and rules [that] are based on but are not identical to
the American Bar Association 'Code of Professional Responsibility and Canons of Judicial
Ethics' (1970)"). State action in standard-setting is exempt from antitrust scrutiny to the
extent that the government involvement meets certain established requirements. See infra
text accompanying notes 241-46.
The proposals made here are also relevant to non-professional standard-setting. However, non-professional standards present less of an antitrust problem for several reasons.
First, the members of industrial standard-setting organizations, unlike those of professional
societies, are in many cases not competitors in the field to which their standards apply.
Second, industrial organizations often do not possess, at least to the extent that professional
societies do, specialized expertise that the general public lacks. Finally, perhaps because
of their relative lack of specialized knowledge, industrial organizations are not deferred
to by the public as readily as are professional societies. See infra text accompanying notes
33-43.
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tion.3 Ideally, the laws protect the ability of consumers to receive the
professional services they desire and the ability of individual professionals to provide those services. In promoting this goal, the laws can
conflict with the activities of professional societies, which directly and
indirectly restrict the services provided by their members. The societies'
activities take a variety of forms, from establishing certification
requirements 4 to enacting codes of ethics 5 and practice standards, 6 but
all are agreements 7 imposing restraints of one form or another on
professional services.' Of course, not all of the restraints are anticompetitive.9 Some benefit not only the professionals themselves, but also
the consumers of professional services as well. Establishing education
and training requirements, for example, both ensures that professionals

3. See Goldfarb v. Virginia State Bar, 421 U.S. 773, 787 (1975) ("The nature of
an occupation, standing alone, does not provide sanctuary from the Sherman Act, nor
is the public-service aspect of professional practice controlling in determining whether § I
includes professions." (citations omitted)).
4. The basic functions of most professional societies are the establishment and
enforcement of membership credentials, which necessarily limit the activities of their
members, both prior to and after joining the society. See PAUL STARR, THE SocIAL
TRANsFORmATION OF AMERICAN MEDICINm 90-91 (1982) (noting that the formation of the
American Medical Association had two basic purposes: to standardize the requirements
for medical degrees and to adopt a code of professional ethics, "with its concern for
excluding sectarian and untrained practitioners"); Clark C. Havighurst & Nancy M. P.
King, Private Credentialing of Health Care Personnel: An Antitrust Perspective (pts. 1
& 2), 9 AM. J. L. & MED. 131, 9 A. J. L. & MED. 263 (1983).
5. See, e.g., American Medical Association, Principles of Medical Ethics (1980);
Council on Ethical and Judicial Affairs, American Medical Association, Current Opinions
(1989) ("intended as an adjunct to the revised Principles of Medical Ethics").
6. See, e.g., American Society of Anesthesiologists, Basic Standards for Preanesthesia Care (1987), Standards for Basic Intra-Operative Monitoring (1986) (amended
1992), Standards for Postanesthesia Care (1988) (amended 1992).
7. See 7 PnmLip E. AREEDA, ANTrrRUST LAW 1477 (1986) ("Although the issue
is seldom discussed, trade associations are routinely treated as continuing conspiracies of
their members, as are bodies promulgating rules or standards for the competitive conduct
of their members, such as the National Society of Professional Engineers.").
8. Of course, professional societies today also serve an important educational role,
independent of their other functions. But the very importance of that role pressures
professionals to join and therefore to comply with the societies' requirements. See MANCUR
OLSON, TaE LoaIc OF COLLECTIVE ACTION: PUBLic GOODS AND THE THEORY OF GROUPS
139-40 (1971 ed.) ("The many technical publications of the American Medical Association,
and the state and local medical societies, also give the doctor a considerable incentive to
affiliate with organized medicine.").
9. As expressed in the Supreme Court's often-quoted statement establishing the
scope of the Sherman Act's § 1, "[t]he true test of legality is whether the restraint imposed
is such as merely regulates and perhaps thereby promotes competition or whether it is

such as may suppress or even destroy competition." Board of Trade of City of Chicago
v. United States, 246 U.S. 231, 238 (1918).
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possess a basic level of competency and communicates information regarding that competency to consumers. 0
However, professional standards, especially in medicine, often go
well beyond the basic requirements for professional competence to
prescribe (or proscribe) particular methods of practice." Because there
are often differences of opinion regarding the appropriateness of particular services, especially when they are new, 2 the establishment of
standards inevitably places some professional services outside the officially accepted area of practice. Furthermore, the standards are generally established by a professional society's mainstream members, who
have a vested interest in continuing to practice by the profession's
established methods. In such a situation, where a group's economic
interests coincide with its regulatory power, skepticism regarding the
exercise of that power is warranted. 3 Indeed, at least one physician
has suggested that a doctor's evaluation of a controversial procedure
can depend on whether he profits from it.' 4 Even putting aside the
problem of immediate economic incentives, it has been observed that
there is a general conservatism and reluctance to accept innovation
15
among professionals.

10. For discussions of both pro and anticompetitive aspects of the certification
process, see Havighurst & King, supra note 4.
11. See David M. Eddy, PracticePolicies-What Are They?, 263 J. A.M.A. 877,
877 (1990) (They are "preformed recommendations issued for the purpose of influencing
decisions about health interventions."); see also Clark C. Havighurst, Practice Guidelines
for Medical Care: The Policy Rationale, 34 ST. Louis U. L.J. 777 (1990) (describing
several recent initiatives, both private and public, that promote practice standards).
12. As an example, even a technique as widely accepted as magnetic resonance
imaging (MRI) was initially the subject of dispute. See Goodman v. Sullivan, 891 F.2d
449, 450 (2d Cir. 1989) (affirming denial of Medicare coverage for MRI treatment on
the ground that it was "not yet generally accepted in the medical profession"). See also
James S. Goodwin & Jean M. Goodwin, The Tomato Effect: Rejection of Highly Efficacious
Therapies, 251 J.A.M.A. 2387 (1984) (describing the medical establishment's rejection of
various effective treatments that did not fit its then-current theories).
13. See Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 500
(1988) ("There is no doubt that the members of such [private standard-setting] associations
often have economic incentives to restrain competition and that the product standards set
by such associations have a serious potential for anticompetitive harm.").
14. See Gina Kolata, Amid FearsAbout a Fetal Test, Many Are Advising Against
It, N.Y. Tmms, July 15, 1992, at C13, col. 4 (quoting Dr. Benjamin Sachs, obstetriciangynecologist-in-chief at Beth Israel Hospital and Harvard Medical School as stating that
in the evaluation of chorionic villus sampling, a prenatal test, "there had been a very
unfortunate 'polarization, depending on whether people make money on the procedure').
15. See, e.g., Gina Kolata, A Tradition of Caution: Confronting New Ideas, Doctors
Often Hold On to the Old, N.Y. Tas, May 10, 1992, § 4, at 6, col. 1:
Doctors generally are "reactionary," said Dr. Jeffrey Isner, a cardiologist
at Tufts University School of Medicine. "As a group, they are relatively slow
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Of course, given the special expertise possessed by professionals,
it is not surprising that much information regarding the practice of
the profession originates with the profession itself. But it is exactly
the advantage in knowledge that professionals possess over the public
that creates a danger of anticompetitive activity. Because consumers
typically have not received professional training, they are unable to
effectively evaluate the professionals' claims for their services. 6 This
would not present a problem if each professional operated independently, and was not subject to the influence of professional societies.
In that case, competing professionals would step in to provide alternative
descriptions of their services, and free competition would prevail. However, very little of the information received by consumers comes from
individual professionals.
Instead, professional societies have taken on the role of providing
a wide range of information and guidance, both to their members and
the public at large. Medical societies, of course, claim that this role
for professional groups is desirable and procompetitive. 7 Legal commentators generally agree, asserting that the societies' production and
communication of information benefit the market because they provide
valuable professional expertise 8 and because they help remedy the
information advantage otherwise possessed by professionals. 9 This might

to accept new ideas. There is a lot of criticism-'Oh, it will never work.' 'Oh,
that's crazy.' A lot of negative responses."
Much of it is a reflection on medical school, specifically which students
are chosen and how they are trained, Dr. Isner said. "You spend a lot of time
learning and memorizing how you're supposed to deal with things," he explained.
"Now someone says, 'We're going to do it a different way.' That means all
your investment is worthless."
See also Joe Sims, Maricopa: Are the Professions Different?, 52 ANTrRUST L.J. 177,
177 (1983) ("[Another] significant distinction between the professions and other occupations
is that many in the former camp actively seek to discourage entrepreneurial efforts by
their counterparts, going so far as to seek to label as unethical (and thus presumably
bad) the use of normal business organization structure for the marketing of services.").
16. See Shapero v. Kentucky Bar Ass'n, 486 U.S. 466, 490 (1988) (O'Connor, J.,
dissenting) ("[M]arket forces, and the ordinary legal prohibitions against force and fraud,
are simply insufficient to protect the consumers of their necessary services from the peculiar
power of the specialized knowledge that [physicians and lawyers] possess.").
17. See AMERICAN MEDICAL ASSOCIATION, LEGAL IMPLICATIONS OF PRACTICE PARAMETERS (1990).

18., See Clark C. Havighurst, Applying Antitrust Law to Collaboration in the
Production of Information: The Case of Medical Technology Assessment, 51 LAw &
CONTmP. PRoBs., Spring 1988, at 341, 350 ("The participation of professional organizations
in technology debates ... offers the public access to a valuable reservoir of knowledge
and insight.").
19. See Thomas L. Greaney, Quality of Care and Market Failure Defenses In
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be true if consumers were assured that the information were accurate,

or if, in case it were inaccurate, equally accessible alternative sources
of information were available. 20 But when a large, respected group

gains a position of dominance from which its voice is virtually the
only one heard, its statements, if incorrect, have a great potential for
harm. 21 This is especially true of a professional group, due to the
difficulty that outsiders have in evaluating that information.
Therefore, a professional society should not be permitted to issue
evaluations describing practices as appropriate or inappropriate without22
ensuring that its statements leave the ultimate choice with consumers.

For example, if there is a possibility that consumers may be misled
by its subjective evaluations, a society should confine its statements
to objective and verifiable facts. 23 The Supreme Court's opinions are
consistent with this view. Its opinions in both the antitrust and commercial speech areas have demanded objectivity from professionals and
standard-setting organizations. 24 Moreover, a society should not be
permitted to indirectly control consumer choices by determining which

Antitrust Health Care Litigation, 21 CoNN. L. REv. 605, 664 (1989) ("Information supplied
in this fashion-evaluating the scientific status of a procedure and the advisability of
routinizing it by deeming it non-'experimenta'-obviously counteracts information asymmetries in the health insurance market.").
20. See Havighurst & King, supra note 4 (pt. 1), at 154 n.72 ("Of course, where
a self-certified group of professionals enjoys a substantial degree of monopoly power,
there exists, by hypothesis, no close competitors who can be counted on to dispute its
unwarranted claims of superiority. In such a case, the primary hope must be for competition
to break out within the monopolistic group itself as individuals and subsets of providers
within the group seek to differentiate themselves from their supposed peers.").
21. See Martin Rose & Robert F. Leibenluft, Antitrust Implications of Medical
Technology Assessment, 314 N. ENG. J. MED. 1490, 1492 (1986) ("[S]ome concern about
antitrust implications is warranted, even in the case of the expression of the opinion of
a medical specialty society, if such expression is likely to have a substantial effect in the
marketplace.").
22. See Havighurst, supra note 18, at 353 ("[A] professional organization pronouncing its opinions on medical technologies is quite likely to believe that its word should
be received not merely as advice, but as gospel. If the effect of its pronouncements is
to perpetuate a professional monopoly over crucial choices concerning medical care, there
would be a problem that might concern an antitrust court.").
23. See infra section III.A. A society may also require its members to refrain from
false or deceptive claims. See infra text accompanying notes 276-77.
24. See, e.g., Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492,
501 (1988) (stating that private standards should be "based on the merits of objective
expert judgments and through procedures that prevent the standard-setting process from
being biased by members with economic interests in stifling product competition."); Peel
v. Attorney Registration and Disciplinary Comm'n of Il., 496 U.S. 91, 110 (1990) (holding
that state licensing boards can require that professionals' advertisements be based on
"objective and consistently applied standards."); see also infra sections II.C. & II.D.
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medical services will be reimbursed by medical insurers. 2s The medical
services market should be permitted to function free of the intervention
of groups of practitioners. 26 As the Supreme Court said in a medical
society case, the antitrust laws serve to prevent agreements that "may
deter experimentation
and new developments by individual entrepre27
neurs."

One would therefore expect the courts to provide a forum where
consumers or professionals suffering from the anticompetitive effects
of society standards could bring antitrust challenges to those standards.

However, to a great extent, the lower courts have failed to let antitrust
law meet that expectation. Until recently, courts often gave professional
standards ad hoc antitrust exemptions that would never be given to
agreements by other groups. The courts deferred to professional societies' judgments regarding, for example, the importance of the scientific method in patient care. 28 More recently, in response to the
Supreme Court's explicit rejection of quality of care defenses, 29 courts
have relied instead on what they characterize as the purely advisory,
non-coercive nature of professional standards.30 This Article presents
25. See infra section III.B.
26. See FTC v. Indiana Fed'n of Dentists, 476 U.S. 447, 462 (1986) ("The Federation
is not entitled to pre-empt the working of the market by deciding for itself that its
customers do not need that which they demand.").
27. Arizona v. Maricopa County Medical Soc'y, 457 U.S. 332, 348 (1982).
28. See Wilk v. American Medical Ass'n, 719 F.2d 207, 227 (7th Cir. 1983)
(approving a jury instruction to the effect that even if the plaintiffs showed that the
defendants' actions restrained competition, rather than promoted it, the defendants would
not be liable if they could show "(1) that they genuinely entertained a concern for what
they perceive as scientific method in the care of each person with whom they have entered
into a doctor-patient relationship; (2) that this concern is objectively reasonable; (3) that
this concern has been the dominant motivating factor in defendants' promulgation of [the
standard at issue] and in the conduct intended to implement it; and (4) that this concern
for scientific method in patient care could not have been adequately satisfied in a manner
less restrictive of competition."), cert. denied, 467 U.S. 1210 (1984). There is no support
in the Sherman Act for this elevation of concern for the scientific method to a privileged
status. The Act is concerned not with the "competition of ideas" engendered by the
scientific method, but with the competition of the market, as even Wilk stated elsewhere
in the opinion. See 719 F.2d at 225 (rejecting the district court's jury instructions because
they were not "geared simply, clearly, and exclusively to the question whether the challenged
conduct promoted or suppressed competition").
29. See, e.g., Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2, 25 n.41
(1984) ("[W]e reject the view of the District Court that the legality of an arrangement
of this kind [tying] turns on whether it was adopted for the purpose of improving patient
care."); National Soc'y of Professional Eng'rs v. United States, 435 U.S. 679, 694 (1978)
("[A] purchaser might conclude that his interest in quality-which may embrace the safety
of the end product-outweighs the advantages of achieving cost savings by pitting one
competitor against another.").
30. See, e.g., Schachar v. American Academy of Ophthalmology, Inc., 870 F.2d
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two responses. First, coercion has never been a requirement for the
application of the antitrust laws. 3' Second, even advisory standards can
have a significant
anticompetitive impact, both on patients and on
2
3

insurers.

The remainder of this Article is divided into four parts. Part I
provides an overview of the nature of the professional standards of
concern in the Article and discusses two recent cases challenging such
standards. Part II describes the applicable legal precedent, particularly
in the Supreme Court, regarding private standard-setting, and discusses
more generally the anticompetitive effects of private medical standards.
Part III offers proposals for determining antitrust liability for medical
standards and discusses how societies can avoid such liability. Part IV
concludes with a discussion of the role professional societies would
play if the proposals of Part III were adopted.
I.

MEDICAL PRACTICE STANDARDS

The specific standards of concern in this Article are those through
which medical societies influence their members' methods of practice.33
They include, for example, standards that regulate particular surgical
techniques3 4 or that mandate the selection of specific medical personnel
to perform certain services.3 It is in these aspects of professional
practice that standard-setting presents particular problems, for two
reasons. First, it is in these areas that professional judgment is most
important, and, therefore, where restrictions on that judgment can be
most harmful. Second, it is also in these areas that outside evaluation
of the standards is most difficult, due to the special expertise of

397, 397-98 (7th Cir. 1989) ("There can be no restraint of trade without a restraint....
[The Academy] did not require its members to desist from performing the operation or

associating with those who do."); see also John E. Lopatka, Antitrust and Professional
Rules: A Framework for Analysis, 28 SAN Dmio L. REv. 301, 309 (1991) ("Obligations'

that are not enforced have little relevance to an analysis of the antitrust implications of
professional rules." (footnote omitted)).
31. See infra section II.A.
32. See infra sections II.B & II.C.
33. See Eddy, supra note 11, at 878 ("Practice policies are extremely versatile. In
addition to supporting individual decisions between practitioners and patients, practice

policies can be used to specify who should perform a practice ([e.g.], accreditation), how
it should be performed ([e.g.], performance criteria), where it should be performed ([e.g.],

inpatient vs[.] outpatient), on whom it should be performed ([e.g.], patient indications),
and whether it will be paid for ([e.g.], precertification criteria and coverage policies.").
34. See infra section I.B.

35. See infra section I.A.
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professionals. 3 6 In other areas, such as price, outsiders (e.g., consumers

of professional services or the courts) are generally
able to evaluate
37
the reasonableness of professional regulations.

In some respects, the professional standards considered here are
similar to standards for manufactured products. 3 In both cases, a
private group issues its judgment as to the acceptability of particular
products or services. However, the anticompetitive problems of pro-

fessional standards are more fundamental than those of industrial
standards. 39 For example, the uniform nature of manufactured products

makes them fitter subjects of standards. Professional services are, or
should be, the antithesis of such products. They should be tailored to
the needs of the individual patient or client in a way that makes them
unsuitable for standardization. 40
More important, though, are the differences in the entities that
establish the two kinds of standards. Industrial standards are often
established by organizations (e.g., Underwriters Laboratories or the
American Society of Testing and Materials) whose primary purpose is

standard-setting. Such organizations are, as the Supreme Court has
observed, "composed of members with expertise but no economic

36. That does not mean, however, that courts should not review such standards.
A court need not conduct a substantive review of the standard itself to determine that
its effect is to deny individual professionals a meaningful opportunity to choose whether
to conform to it.
37. Price-related standards have received more attention from the Supreme Court
than have other practice standards. See, e.g., Arizona v. Maricopa County Medical Soc'y,
457 U.S. 332 (1982); Goldfarb v. Virginia State Bar, 421 U.S. 773 (1975); National Soc'y
of Professional Eng'rs v. United States, 435 U.S. 679 (1978); but see FTC v. Indiana
Fed'n of Dentists, 476 U.S. 447 (1986) (agreement not to provide x-rays for review by
insurers).
38. Standards for industrial products are exemplified by those at issue in two recent
Supreme Court cases. See Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S.
492 (1988); American Soc'y of Mechanical Eng'rs, Inc. v. Hydrolevel Corp., 456 U.S.
556 (1982).
39. This is not to say that the anticompetitive dangers of industrial product standards
are insignificant. See, e.g., 7 P mjup E. AREEDA, AtnTRUST LAW 1503a (1986) ("Product
standardization might impair competition in several ways.... Such standardization might
deprive some consumers of a desired product, eliminate quality competition, exclude rival
producers, or facilitate oligopolistic pricing by easing rivals' ability to monitor each other's
prices.").
40. See Virginia State Bd. of Pharmacy v. Virginia Citizens Consumer Council,
Inc., 425 U.S. 748, 773 n.25 (1976) ("Physicians and lawyers, for example, do not dispense
standardized products; they render professional services of almost infinite variety and
nature ..... " (emphasis in original)); see also Shapero v. Kentucky Bar Ass'n, 486 U.S.
466, 487 (1988) (O'Connor, J., dissenting) (noting the "defective analogy between professional services and standardized consumer products").
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interest in suppressing competition.' '41 Professional standards, in contrast, are established by organizations whose members are providers
of the services to which the standards apply. The temptation is great

for a provider to promote standards favorable to his own services. It
is this danger on which the Supreme Court has focused in its opinions
regarding standard-setting associations: 42 "There is no doubt that the

members of such associations often have economic incentives to restrain
competition and that the product standards set by such associations
4
have a serious potential for anticompetitive harm.
The following sections discuss the realization of that potential as

evidenced in 'two recent cases challenging medical society standards
directed at two different groups: patients and third-party payers of

medical bills. 44 It will be apparent that the facts in these cases are not
well developed. That is in part because they arose on motions for
summary judgment. However, as is argued in Parts II and III, it is
also partly due to the courts' failure to recognize the nature of the

potential anticompetitive harm in these cases. This has resulted in a
focus, by both courts and litigants, on more peripheral issues. In any
event, the point here is not to prove that the actions in these particular

41. Allied Tube & Conduit Corp., 486 U.S. at 510 n.13. As an example, the Court
cited Sessions Tank Liners, Inc. v. Joor Mfg., Inc., 827 F.2d 458 (9th Cir. 1987), vacated
on other grounds, 487 U.S. 1213 (1988). The trade association in Sessions allowed industry
members to serve on committees considering new standards and to participate in hearings
regarding them, but it permitted only public officials to vote on the standards. Id. at
460-61.
42. It is notable that in the cases that the Supreme Court has heard regarding
industrial standards, the organizations involved were trade associations more akin to
professional societies than to pure standard-setting organizations. See Allied Tube & Conduit
Corp. v. Indian Head, Inc., 486 U.S. 492 (1988); American Soc'y of Mechanical Eng'rs
v. Hydrolevel Corp., 456 U.S. 556 (1982); Radiant Burners, Inc. v. Peoples Gas Light
& Coke Co., 364 U.S. 656 (1961) (per curiam).
43. Allied Tube & Conduit Corp., 486 U.S. at 500 (footnote and citation omitted);
see also American Socy' of MechanicalEng'rs, 456 U.S. at 571 ("Furthermore, a standardsetting organization like ASME can be rife with opportunities for anticompetitive activity.
Many of ASME's officials are associated with members of the industries regulated by
ASME's codes. Although, undoubtedly, most serve ASME without concern for the interests
of their corporate employers, some may well view their positions with ASME, at least in
part, as an opportunity to benefit their employers.").
44. Although the text speaks of standards' effects on patients and third-party
payers, it is likely that, to the extent those effects are anticompetitive, they would be
challenged not by those groups themselves, but by physicians affected indirectly through
decreased demand for their services. See infra sections III.A and III.B. It is one of the
main points of this Article that much of the doctrinal confusion in this area is caused
by a failure to distinguish between direct effects on providers, which reduce supply, and
indirect, but still anticompetitive, effects on them, which are produced by a reduction in
demand by consumers.
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cases were anticompetitive. The point is to examine the true nature of
the harm to competition in these cases and to show the economic
incentives that medical societies have in enacting their standards.
A.

The Effects of Standards on Patients

Koefoot v. American College of Surgeons4 was a dispute between
the American College of Surgeons (ACS) and Dr. Robert Koefoot,
formerly a fellow of the ACS, regarding the ACS's rule forbidding
"itinerant surgery." 46 The ACS defined "itinerant surgery" as surgery
"under circumstances in which the responsibility for diagnosis or care
of the patient is delegated to another who is not fully qualified to
undertake it.'' 47 Because the ACS's position was that a physician was
not qualified to provide post-operative care unless he was as qualified
as the operating surgeon, the rule effectively reserved all post-operative
care to surgeons. 41
Dr. Koefoot practiced in rural Nebraska and performed some "typically less complex and more routine" surgery at hospitals outside the
city where his practice was based. 49 Post-operative care for those procedures was provided by general practitioners at the hospitals. Dr.
Koefoot admitted that this practice constituted "itinerant surgery" as
defined by the ACS, but he refused to stop it, and he was first suspended
and then expelled from the ACS. The ACS's position was that "[i]f
Dr. Koefoot chooses not to drive 20 miles to [the local hospitals] to
see his patients, if Dr. Koefoot disagrees with the College policy, or

45. 610 F. Supp. 1298 (N.D. Ill.
1985).
46. See generally id. at 1300-03.
47. Id. at 1300.
48. Id. at 1300, 1303. According to the plaintiffs' allegations, the rule "inhibited
the ability of rural community hospitals to compete with hospitals in major metropolitan
areas, of surgeons in Dr. Koefoot's position to compete with local surgeons, and of
general practitioners to compete with surgeons in the provision of post-operative care."
Id. at 1303.
49. The court provided the following description of medical practice in Nebraska:
Plaintiffs provide medical care in the State of Nebraska, largely a rural
state consisting of 92 counties, comprising approximately 70,000 square miles.
In 1980, there were approximately 2,300 doctors in Nebraska, of whom 181
were general surgeons, such as Dr. Koefoot. Over 70% of the state's population
resides in 21 of the 92 counties, located in and around the major cities of
Omaha and Lincoln. Those 21 counties had 89% of the physician population,
leaving only 247 physicians to serve the remaining 71 counties with their 457,000
residents. The state has 116 hospitals. The area outside that known as the "Fish
Hook" has only 247 physicians to serve over 63,000 square miles and 450,000
people, a ratio of 1,850 people per doctor. Thus, the practice of rural medicine
in Nebraska is vital to the health of its general populace.
Id. at 1301.
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if Dr. Koefoot chooses to spend his time on pursuits other than surgery,
that is his perfect right. But he may not call himself a Fellow of the
American College of Surgeons." 50
Dr. Koefoot alleged that he suffered a variety of injuries as a
result of this dispute. He said that his surgery practice declinedsl and
that he suffered a variety of professional injuries. 52 It is important to
note, however, that it was apparently only the latter injuries that
stemmed from his expulsion from the ACS. For example, Dr. Koefoot
said that the expulsion made it difficult for him to hire an associate,
reduced the frequency with which he was employed as an expert witness,
and injured his relationships with other doctors. 53 All of these injuries
related to Dr. Koefoot's dealings with his fellow professionals, not his
dealings with patients. He did not allege that his surgical practice was
harmed by the expulsion.
Instead, Dr. Koefoot attributed the decline in his practice to "the
publicity resulting from the disciplinary charges of unethical surgery
relating to the delegation of post-operative care of patients under [his]
supervision to family practitioners," and said that patients had declined
to have surgery in their local hospitals "because of the accusations of
unethical surgery." ' 54 These claims can be interpreted in two ways. The
patients might have declined to receive surgery from Dr. Koefoot
because of charges that he practiced in an unethical fashion, or they
might have declined to receive itinerant surgery from anyone, including
Dr. Koefoot, because of the allegations that the practice itself was
unethical. In either case, the injuries to Dr. Koefoot's practice were
caused by the influence the ACS's rule had on the decisions of his
potential patients, not by his expulsion. 5" There is no mention in the

50.
51.

Id. at 1303.
Id. at 1307-09.

52.

Id. at 1307-08.

53.

Id. at 1308.

54. Id. at 1308-09.
55. It does not appear from the case that the ACS publicized its expulsion of Dr.
Koefoot. In any event, he could have suffered the same damage from negative publicity
regarding his practice methods even if he had never been a member. An informative
contrast is provided by Kreuzer v. American Academy of Periodontology, 735 F.2d 1479
(D.C. Cir. 1984), which reversed a grant of summary judgment in favor of the defendant
medical society. The society standard in Kreuzer, similar to that in Koefoot, required the

society's "active" members to confine their practices solely to periodontology. However,
the focus of the Kreuzer court was on the society's policy, when contacted by potential
patients, to provide referrals only to active members, as defined by the standard. The
court observed that the standard harmed consumers in two ways: (1) they would never
be referred to periodontists who refused to conform to the society's rule, thus limiting
the number of periodontists available to them, and, therefore, increasing the market price;
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case that patients were even aware of his expulsion from, or his prior
membership in, the ACS.
Thus, merely by calling Dr. Koefoot's method of practice "unethical," his competitors in the ACS were able to damage his business.
And they had an obvious economic interest in doing so. Any rule that
justified a surgeon's refusal to allow another, perhaps lower-paid physician to perform post-operative care preserved the income from that
service for the surgeon. The director of the ACS had even admitted
that one of the purposes of the rule was to protect surgeons in local
practices: "We had been thinking in terms of the practice of itinerant
surgery freezing out young men who might wish to come into a
community to practice.''56 The ACS claimed that the rule was necessary
to assure "the highest quality post-operative care," 5 7 but it apparently
presented no evidence for that claim. Dr. Koefoot asserted that he had
an "extremely low rate of post-operative complications." '
Under these circumstances, it is reasonable to question the ACS's
condemnation of itinerant surgery. Consider the following comment
from the District of Columbia Circuit considering a similar society
rule:
[W]e can set the following standard for application of a rule
of reason analysis to questioned conduct of professional associations justified under a patient care motive. When the
economic self-interest of the boycotting group and its proffered
justifications merge the rule of reason will seldom be satisfied.5 9
This well-describes the danger presented when a group of competitors
has the power to issue influential standards regarding its own practices
and those of competing groups. In Koefoot, where the ACS apparently
was unable to provide any evidence that patient care benefitted from
its rule against itinerant surgery, or any reason for labelling the practice
"unethical," it seems likely that the rule was based more on the ACS's
competitive goals than on any desire to convey information. This is
not to say that medical societies always, or even often, use their
statements to influence competition without regard to truth. The point

and (2) they could not receive additional non-periodontal care from society members,
denying them the benefits of one-stop dental service. Id. at 1493-94. Thus the harm in
Kreuzer was caused by the effects of the society's rule on the choices of periodontists,
not by the effect of the rule on patient demand, which is the focus of this Article.
56. Koefoot, 610 F. Supp. at 1305 (quoting the director of the ACS).
57. Id.at 1303.
58. Id.
59. See Kreuzer v. American Academy of Periodontology, 735 F.2d 1479, 1494
(D.C. Cir. 1984). This case is described in note 55 supra.
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is simply that society statements do have competitive effects and that,

in cases like Koefoot, those effects can be produced in the absence of
any objective support for the statements. The next section describes

another avenue for society action affecting competition.
B.

The Effects of Standards on Third-Party Payers

Schachar v. American Academy of Ophthalmology, Inc.60 involved

a new ophthalmological procedure known as radial keratotomy. 61 The
incidents that gave rise to the case began in 1976.62 In that year, Dr.
Leo Bores visited the Soviet Union and performed several radial keratotomies; he returned the following year to examine his patients. He
performed the first radial keratotomy in the United States in 1978,
and in 1979 he formed, with seven other eye surgeons, the National
Radial Keratotomy Study Group (NRKSG). The NRKSG developed a

protocol for use in performing the procedure and created a detailed
informed consent form to be reviewed by patients undergoing the
63
procedure.
In March, 1980, Dr. George Waring joined the NRKSG. Later that
month, Dr. Waring convened a meeting of a different group of fourteen
eye surgeons to discuss radial keratotomy and the possibility of getting
a government grant to study the procedure. Dr. Waring then contacted

Dr. Ronald Geller of the National Advisory Eye Council (NAEC), an

60. 1988-1 Trade Cases (CCH) 67,986 (N.D. Ill.). Some of the factual history
related in the text comes from Vest v. Waring, 565 F. Supp. 674 (N.D. Ga. 1983), another
case involving many of the same parties and issues. Although some of the facts presented
here might therefore not have been before the court in Schachar, they are given to provide
a more complete story, and because they do not change the analysis of the issues involved.
61. Radial keratotomy is a surgical procedure for the correction of nearsightedness.
Nearsightedness occurs where the cornea focuses visual images in front of the retina rather
than exactly on it, which results in an out-of-focus retinal image. Radial keratotomy
corrects this problem by making shallow incisions radially on the surface of the cornea,
which causes it to flatten slightly. The flatter cornea focuses images farther back in the
eye, so vision is improved.
The procedure has had mixed results. See Jane E. Brody, Study Cites Risks in an
Operation for Myopia, N.Y. TuMs, Feb. 23, 1990, at A20, col. I (noting that some
patients receive undercorrection or overcorrection, and that ophthalmologists disagree
regarding the effectiveness of the procedure). See also George 0. Waring III et al., Results
of the Prospective Evaluation of RadialKeratotomy (PERK)Study 4 Years After Surgery
for Myopia, 263 J. A.M.A. 1083 (1990); Perry S. Binder, Radial Keratotomy in the 1990s
and the PERK Study, 263 J. A.M.A. 1127 (1990).
62. See generally Schachar, 1988-1 Trade Cases (CCH)
67,986, at 58,050-51;
Vest, 565 F. Supp. at 676-83.
63. Vest, 565 F. Supp. at 677.
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advisory committee" for the National Eye Institute (NEI), which provides federal funding for vision research. Dr. Geller indicated that the
NEI was interested in funding research in radial keratotomy, and Dr.
Waring's group met again in May to make plans for submitting a
proposal for a study called the Prospective Evaluation of Radial Keratotomy (PERK).

Shortly after that May meeting the NAEC issued a statement that
"[t]he Council considers radial keratotomy to be an experimental procedure because it has not been subjected to adequate scientific evaluation
in animals and humans. ' 65 The issuing of the NAEC statement was
followed by similar statements6 6 from ophthalmological and medical
associations in several states, 67 orchestrated, the plaintiffs alleged, by

64. Federal advisory committees are governed by the Federal Advisory Committee
Act, 5 U.S.C. App. 2. Such committees, though nominally public agencies, may themselves
put private interests over those of the public. See Sidney A. Shapiro, Public Accountability
of Advisory Committees, 1 RIsK IssuEs iN HE.ALT & SA'ETY 189 (1990).
65. Vest, 565 F. Supp. at 678 n.6.
66. In this Article, the terms "standard" and "statement" are used, for the most
part, interchangeably. Because the "statements" discussed are official communications of
the societies involved, any technical differences that might exist between the two terms
are not relevant here.
67. Vest, 565 F. Supp. at 679-80 n.8 (Georgia), 680 n.9 (New Mexico), 680-81
n.10 (Florida), 681 n.11 (Arizona). Following is the Arizona statement:
RESOLVED, that,
1. The Arizona Ophthalmological Society (AOS), a group of physicians
primarily concerned with eye care, expresses their concern about potential widespread [sic] adoption of an operation intended to correct nearsightedness, a
common condition that can be easily and safely corrected by the use of eyeglasses
or contact lenses.
2. The operation called Radial Keratotomy has received widespread publicity
during the last two years. It involves cutting the cornea with a series of deep
incisions that extend from the sclera toward, but not into, the center of the
cornea. The incisions are intended to be deep enough so that internal eye pressure
causes the edge of the cornea to bulge slightly, thereby flattening the central
portion of the cornea which improves focusing. The incisions result in permanent
scars.
3. The AOS considers Radial Keratotomy to be an "experimental" procedure
because it has not been subjected to adequate scientific evaluation in animals
and humans.
4. The AOS endorses the conclusions of the National Keratotomy Workshop
of March 15, 1980; and the National Advisory Eye Council (NAEC) Resolution
approved May 29, 1980, concerning Radial Keratotomy.
5. The AOS urges restraint on the part of both Arizona Ophthalmologists
and patients regarding the procedure until results of research known as the
Prospective Evaluation of Radial Keratotomy (PERK) study of the National Eye
Institute (NEI) are obtained and fully evaluated.
6. The AOS urges that its view on the subject of Radial Keratotomy as
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the American Academy of Ophthalmology. 68 All of them, purportedly

following the NAEC, declared radial keratotomy to be "experimental."' 69 In addition, despite the fact that some of the statements were
issued before any PERK grants were awarded, they condemned in
various terms the performance of radial keratotomy outside the confines
of the PERK study. For example, the Georgia motion said that "[e]ach
member of the [Georgia Ophthalmological] Society in good standing
will agree to refrain from participating in such surgery outside the
framework of [the PERK] study, for a period of one year, or until
results indicate the technique is safe and effective." ' 70 The original
Florida statement was nearly identical to the Georgia one, but it was
later withdrawn, and a somewhat less restrictive statement substituted.
The new statement, tellingly, included the NRKSG study among the
7
approved programs. '
The plaintiffs alleged that the statements issued by the societies

decreased demand for radial keratotomies. It was not clear in this case,
however, whether the decrease was caused by reduced demand from
the patients themselves or by less willingness on the part of their

insurers to pay for the procedure. 72 There was no specific evidence
reported in the cases regarding whether patients were discouraged from
seeking the services. 73 It is clear, though, that the intent of the societies'
statements was to discourage patients from seeking the procedure, at

expressed in this resolution be announced to the general public, other health
care professionals, institutions, including institutional review committees, and
third party insurers and payers in Arizona; therefore be it
RESOLVED,
That the Arizona Medical Association endorses and supports the resolution
of the Arizona Ophthalmological Society concerning the procedure known as
Radial Keratotomy until the safety and efficacy of the procedure have been
carefully demonstrated in controlled studies.
Id.at 681 n.11.
68. Schachar, 1988-1 Trade Cases (CCH) 67,986, at 58,050-51.
69. Vest, 565 F. Supp. at 679-80 n.8, 680 n.9, 680-81 n.10, 681 n.11.
70. Id.at 680 n.8.
71. Id.at 680-81 n.10.
72. Indeed, in Vest the plaintiffs included potential patients who wanted to receive
radial keratotomies, but were hindered in doing so by the societies' statements. Id. at
682.
73. However, the notice issued in Vest when a settlement agreement was reached
in the case notes that one of the conditions of settlement was that Dr. Waring would
issue a statement that radial keratotomy was no longer "experimental" and that "[p]laintiffs
also anticipate that the statement will encourage public employers to accept applicants
who have had the procedure performed on them." Vest v. Waring, No. C82-325A, Revised
Notice to Class Members, at 2 (N.D. Ga. Mar. 25, 1985). Apparently, then, some of
those employers had been unwilling to hire patients who had received radial keratotomies,
due at least in part to the societies' statements regarding the procedure.
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least outside of the PERK study. 74 The statements explicitly said that
they were intended to "be announced to the general public. ' " T7 More76
over, the statements' use of dramatic, if not inflammatory, language
could only have been directed at the public.
But most of the reduced patient demand for radial keratotomies
in Schachar was apparently caused by decisions by third-party payers
not to reimburse for the procedure. 77 After the NAEC and the state
medical societies issued their statements, several insurance companies
made such decisions. 78 The plaintiffs alleged that the American Academy
of Ophthalmology was instrumental in causing insurance companies to
take that action.7 9 It accomplished this, the plaintiffs claimed, through
its membership in the Council of Medical Specialty Societies (CMSS),
which is associated with the Health Insurance Association of America
(HIAA). The HIAA is an organization of insurance companies which
together account for approximately eighty-five percent of health insurance in the United States. 0 When the academy classified radial
keratotomy as experimental, the CMSS transmitted that information
to the HIAA through a newsletter under a heading entitled "Procedures
Which Should Not Be Reimbursed Routinely by Third Party Payers
Without Written Justification." ' Insurers apparently followed this in82
struction.

74.

The goal of the PERK group was not to eliminate radial keratotomy altogether,

but only to confine its practice to their study. They were not, therefore, intending to
convey the message that radial keratotomy was unsafe, but only that its safety and
effectiveness were unproven and, further, were only appropriately tested in their study.
Even this, however, was questionable. There was no evidence that the PERK group
provided better care or more useful research than the NRKSG (Dr. Bores's group). As
mentioned above, the NRKSG had developed and implemented its own research protocol.
See supra text accompanying note 63.
75. E.g., Vest, 565 F. Supp. at 681 n.11.

76. This sort of evaluation is necessarily subjective, but to express "concern" about
an "experimental" procedure that involves "deep incisions" into the cornea, resulting in

"permanent scars," though perhaps not technically inaccurate, seems calculated more to

alarm than to inform. This is especially so in light of the absence, discussed in the text,
of efforts to place the statements in any objective context. For the full text of the statement
including these descriptions, see note 67 supra.
77. This result is not unique to the medical field. In the industrial area, a product's
failure to meet a standard can also result in third-party insurers' unwillingness to provide
insurance where the product is used. See Allied Tube & Conduit Corp. v. Indian Head,
Inc., 486 U.S. 492, 495-96 (1988).
78. Vest, 565 F. Supp. at 681-82.
79. Schachar, 1988-1 Trade Cases (CCH) 67,986, at 58,051.
80. Id.
81. Id.
82. In addition, the case reports that some hospitals do not allow "experimental"
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The adoption by insurers of medical society decisions on these
matters is not surprising. Both private 3 and public 4 insurers rely heavily
on medical society assessments of services. The societies are generally
consulted in determining whether a given service should be covered by
the patient's policy, which most often excludes procedures that are

"experimental."" 5 As described above,86 the state medical societies ap-

procedures to be performed in their operating rooms, so that after the statements were
issued surgeons were no longer permitted to perform radial keratotomy in those hospitals'
operating rooms. Vest, 565 F. Supp. at 682. This made the purchase of personal surgical
equipment necessary for those surgeons who wished to continue performing the surgery.
Id. Hospitals are not, of course, third-party payers, but the effects of their actions were
in some ways analogous to the payers' actions. The increased costs incurred by the affected
physicians would have resulted in higher costs to their patients, as did third-party payers'
decisions not to reimburse for the procedure. The higher costs would have reduced the
affected physicians' output of radial keratotomies, benefiting their competitors. See Thomas
G. Krattenmaker & Steven C. Salop, Anticompetitive Exclusion. Raising Rivals' Costs to
Achieve Power over Price, 96 YAL L.J. 209 (1986); Steven C. Salop & David T. Scheffman,
Raising Rivals' Costs, 73 AM. EcoN. REv. (Papers & Proceedings) 267 (1983). Moreover,
the hospitals apparently directly accepted the societies' evaluations of the procedure in
much the same was as did third-party payers, as discussed in this section and section
III.B infra.
83. See INsTrruTE oF MEDicINE, AssEsING MEDICAL TECHNOLOGIES 2 (1985) ("Blue
Cross and Blue Shield Association and other major insurers increasingly seek assistance
from medical associations such as the American College of Physicians, the American
College of Radiology, and the American College of Surgeons in formulating coverage
policies.").
84. See Health Care Financing Administration, Medicare Programs; Criteria and
Procedures for Making Medical Services Coverage Decisions That Relate to Health Care
Technology, 54 Fed. Reg. 4302, 4311 (1989) (Medicare coverage decisions by private
contractors "are usually made in consultation with the contractor's own medical staff and
local medical specialty groups.").
85. A typical coverage provision excludes .'[a]ny treatment or procedure, medical
or surgical, or any facilities, drugs, drug usage, equipment, or supplies which are Experimental or Investigative."' Thomas v. Gulf Health Plan, Inc., 688 F. Supp. 590, 593
n.2 (S.D. Ala. 1988) (quoting coverage exclusion). Medicare coverage has similar limitations,
derived from the Social Security Act's requirement that a covered procedure be "reasonable
and necessary." See 42 U.S.C. § 1395y(a)(1)(A). The Department of Health and Human
Services's Health Care Financing Administration has interpreted this requirement to mean
that a procedure must be (1) safe and effective, (2) not experimental or investigational,
and (3) appropriate. Health Care Financing Administration, Medicare Programs; Criteria
and Procedures for Making Medical Services Coverage Decisions That Relate to Health
Care Technology, 54 Fed. Reg. 4302, 4307 (1989). Under this test, a procedure's experimental status would presumably be sufficient in itself to preclude its coverage, but an
experimental procedure is also unlikely to satisfy the other two criteria, given their close
interdependence. See INsTrrum OF MEDICINE, AssEssING MEDICAL TEcHNoLoGms 5 (1985)
("Safety and effectiveness are addressed only indirectly in some evaluations; payers generally
rely on a determination of a technology's diffusion, i.e., whether it is standard practice
rather than experimental or investigative, as an indicant of a physician's judgment of its
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plied this label to radial keratotomy, which caused insurers to refuse
to reimburse for it. There is reason to think that professional societies
should not be permitted to exercise such power.

A basic problem is that there is no objective definition of "experimental." The Health Care Financing Administration has proposed
regulatory guidelines for evaluating a treatment's experimental status,
but to the extent that they are not circular, 7 they rely on general
acceptance by the medical community." Therefore, the evaluation is
an imprecise process, and determination of which procedures are experimental has been extremely inconsistent, even in the presumably
impartial forum of the court system. 9 Even more significantly, the use
of acceptance by the medical community as the evaluation criterion
has inherent problems when it is a subgroup of that same community
that is making the evaluation and that subgroup has an economic
interest in the outcome.
The evaluation of radial keratotomy in Schachar, made by the
medical societies and allegedly influenced by the PERK group, was a
self-interested one. 90 Recall that the effect of the societies' efforts was

safety and effectiveness."); Health Care Financing Administration, Medicare Programs;
Criteria and Procedures for Making Medical Services Coverage Decisions That Relate to
Health Care Technology, 54 Fed. Reg. 4302, 4308 (1989) ("Among the many relevant
considerations [in evaluating appropriateness], safety and effectiveness are the key factors
for our review.").
86. See supra text accompanying notes 65-69 & 77-82.
87. See Health Care Financing Administration, Medicare Programs; Criteria and
Procedures for Making Medical Services Coverage Decisions That Relate to Health Care
Technology, 54 Fed. Reg. 4302, 4316 (1989) ('Experimental' means a technology that
should be confined to a research setting under which human or animal subjects are
assigned, in accordance with predetermined rules.").
88. See id. at 4307-08 ("Has the service been generally accepted by the medical
community, and has it emerged from the research stage?").
89. See Richard S. Saver, Note, Reimbursing New Technologies: Why Are the
Courts Judging Experimental Medicine?, 44 STr. L. Rnv. 1095, 1098-1104 (1992).
90. The court outlined the plaintiffs' description of the process as follows:
The Academy commissioned its Eye Banks Committee to determine the status
of radial keratotomy, although the committee members were unqualified to do
so, and it declared the procedure experimental. In March of 1980 at the Academy's
direction various co-conspirators held a meeting at the Atlanta airport and also
concluded that radial keratotomy should be designated experimental. Defendants
then began a national campaign to pressure state and local medical societies,
governmental agencies and hospital staffs to declare a moratorium on radial
keratotomy until self-appointed academicians could study the procedure and
decide whether it should be approved.
Schachar, 1988-1 Trade Cases (CCH) 67,986, at 58,050-51.
There is some indication that the evaluations of radial keratotomy were not based
solely on scientific considerations. The NAEC first declared radial keratotomy experimental
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not to halt the practice of radial keratotomy, but to reserve the practice
of it, even in research, to the PERK group's academic studies. 91 This
was true despite the absence of any, showing of a significant difference
between the PERK study and Dr. Bores's (non-academic) NRKSG work.
As described above, 92 Dr. Bores's NRKSG was not performing radial
keratotomies indiscriminately, but had itself established a research protocol for the procedure. There was no showing, or even any allegation,

that the NRKSG was performing radial keratotomies irresponsibly. The
main difference between its work and that of the PERK study was
apparently that the NRKSG's patients paid for the procedure, while

patients in the PERK study did not. Although the ophthalmologists
in the NRKSG therefore stood to gain from performance of the procedure, and thus had an economic interest at stake, so did the PERK
ophthalmologists. 93 Dr. Waring and the other ophthalmologists in the
study were compensated for their work as part of the grant. 94 Moreover,
even if they had not been paid, the receiving of a grant has significant
implications for career advancement for an academic researcher. Therein August, 1979. Vest v. Waring, 565 F. Supp. 674, 677 n.3 (N.D. Ga. 1983). At that
time the NAEC stated that "[n]o clinical research employing refractive keratoplasty [i.e.,
radial keratotomy] should be supported by the National Eye Institute (NEI) until the
results of animal research can be evaluated." See 18 Investigative Ophthalmology and
Visual Science 882 (1979). However, on May 28, 1980, shortly after the meeting between
Dr. Waring's study group and Dr. Ronald Geller of the NAEC, the Council changed its
opinion and "urged the [National Eye Institute] to 'take whatever measures are necessary
to encourage research in radial keratotomy ... in scientifically designed clinical trials
conducted by qualified investigators."' See Vest, 565 F. Supp. at 678. The turnaround
just as the PERK group was lobbying the NAEC for a research grant seems more than
coincidental.
It is also notable that Dr. Waring himself eventually decided that he could approve
radial keratotomy as part of a settlement agreement in Vest. The settlement notice included
the following statements:
[O]ne of the Defendants, Dr. George 0. Waring, has agreed to issue a statement
which will be released when the proposed settlement becomes final. The statement
is intended to set forth certain current and historical facts about the radial
keratotomy procedure, and states, inter alia[,] that enough information is now
available to establish that radial keratotomy is not an experimental procedure.
Vest v. Waring, No. C82-325A, Revised Notice to Class Members, at 2 (N.D. Ga. Mar.
25, 1985).
91. See supra text accompanying notes 70-71.
92. See supra text accompanying note 63.
93. The third-party payers also have economic interests in the evaluations. Because
insurance companies usually receive payment per capita, they have every reason not to
cover a service if they can justify non-payment. Therefore, any effort by a society to
persuade an insurer to eliminate reimbursement is likely to be readily accepted.
94. They probably continued to receive their paychecks from academic institutions,
of course. But research grants typically include compensation for the researchers, paid to
institutions for their benefit.
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fore, it was in the PERK group members' economic interests to establish
that radial keratotomy was experimental before widespread practice of
the procedure provided data regarding its efficacy; otherwise, there
would have been no need for their study. Furthermore, establishing
the societies' rules that no radial keratotomies should be performed
outside their study assured the PERK group of patients who might
otherwise have preferred to receive the procedure without the additional
burden of the experimental procedure. 95
Thus, as in Koefoot, the defendants in Schachar were able to use
the influence of their medical societies to injure the practices of their
competitors. Again, as with Koefoot, it should be emphasized that this
is not to say that the medical society evaluations were necessarily
wrong. And even if they were, it is not to say that any members of
either of the radial keratotomy study groups intentionally made false
statements regarding the procedure. The point is only that the economic
interests of the participants and the potential for effects on competition
argue for a critical analysis of the society statements. The next two
Parts of this Article provide a framework for that analysis.

II.

CURRENT LEGAL STANDARDS

The facts in Koefoot and Schachar appear to make prima facie
cases of combinations to restrain trade. Both trial judges thought so
and denied the defendants' motions for summary judgment. 96 Nevertheless, in both cases the juries found for the defendants. 97 Although
this may truly indicate that the societies' actions were, on balance,
procompetitive, the economic incentives and anticompetitive potential
discussed in Part I suggest that other possibilities should be considered.
One is that the juries might have deferred to the professionals' justifications for their actions more readily than they would have for
other groups. This possibility seems plausible when one considers that
juries have returned plaintiffs' verdicts against non-professional trade
associations in somewhat similar cases. 98 However, another possibility
is that the medical societies received deference not from the juries but
from the courts. Koefoot and Schachar may have had jury instructions

95. See Havighurst, supra note 18, at 370 (discussing denial of consumer choice
in conduct of clinical trials).
96. Schachar, 1988-1 Trade Cases (CCH) 67,986; Vest, 565 F. Supp. 674.
97. See Schachar v. American Academy of Ophthalmology, Inc., 870 F.2d 397,
398 (7th Cir. 1989) (noting jury verdict for defendants); Koefoot v. American College of
Surgeons, 692 F. Supp. 843, 845 (N.D. Ill. 1988) (same).
98. See, e.g., Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492,
497-98 (1988) (noting jury verdict for plaintiff); American Soc'y of Mechanical Eng'rs v.
Hydrolevel Corp., 456 U.S. 556, 565 (1982) (same).
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similar to those in Wilk v. American Medical Association,99 another
society standard case that produced a jury verdict for defendants.
Those instructions could not "be defended successfully as an adequate
approximation of a rule of reason test geared simply, clearly, and
exclusively to the question whether the challenged conduct promoted
or suppressed competition."00

Support for this explanation can be found in the opinion of the
Seventh Circuit affirming the verdict in Schachar. This opinion, by
Judge Easterbrook, sounded two notes often heard in professional
society cases:
[The Academy] did not require its members to desist from
performing [radial keratotomies] or associating with those who
do. It did not expel or discipline or even scowl at members
who performed radial keratotomies.' 0 1
An organization's towering reputation does not reduce its freedom to speak out. Speech informed, hence affected, demand
for radial keratotomy, but the plaintiffs had no entitlement to
consumers' favor. The Academy's declaration affected only the
demand side of the market, and then only by appealing to
consumers' (and third-party payors') better judgment. If such
statements should be false or misleading or incomplete or just
plain mistaken, the remedy is not antitrust litigation but more
speech-the marketplace of ideas. 10 2
If the trial courts gave jury instructions in line with these statements,
it is not surprising that the juries decided for the defendants. As Judge
Easterbrook points out, the Academy in Schachar did not force its
members or others to cease providing radial keratotomies. Instead, it
and the ACS in Koefoot were able to influence patients and thirdparty payers to cease buying the services they disapproved. Contrary
to Judge Easterbrook's view, however, that should not remove the
societies' actions from the reach of the antitrust laws. 0 3
99. 719 F.2d 207, 211 (7th Cir. 1983) (noting jury verdict for defendants), cert.
denied, 467 U.S. 1210 (1984). Wilk was subsequently retried (on a more limited set of
issues) without a jury, and the trial judge found for the plaintiff. See Wilk v. American
Medical Ass'n, 671 F. Supp. 1465 (N.D. Ill.
1987), aff'd, 895 F.2d 352 (7th Cir. 1990),
cert. denied, 476 U.S. 927 (1990).
100. Id. at 225. In contrast, the Supreme Court in Allied Tube specifically noted
that "[t]he jury, instructed under the rule of reason that respondent carried the burden
of showing that the anticompetitive effects of petitioners's actions outweighed any procompetitive benefits of standard setting, found petitioner liable." 486 U.S. at 497-98.
101. Schachar, 870 F.2d at 398.
102. Id. at 399-400.
103. Even commentators who are generally sympathetic to society standard-setting

INDIANA LAW REVIEW

A.

[Vol. 27:51

Anticompetitive Effects on Demand

As a preliminary matter, it is clear that some medical standards,
such as the one in Koefoot, do have a coercive effect. Although Dr.
Koefoot did not give up his practice of what the ACS called "itinerant
surgery," he was thereby forced to give up his ACS membership. 1' 4 It
would be a cramped definition of coercion that excluded a rule with
effects like these from its reach. "Coercion" is present not only when
the society member has no choice at all, but also when the society
exercises some degree of undue influence.105
In any event, the view that coercion is necessary to establish an
antitrust violation is simply wrong. In Schachar, Judge Easterbrook cited

several trade association cases in which standards were found anticom-

petitive, and he said that in those cases the standard was enforced. 1 6

However, his characterization of those cases was at best disingenuous.
Several of the cases cited involved only standard-setting, not enforcement,

or explicitly said that coercion was not necessary to find a violation.1'°

have expressed skepticism about Judge Easterbrook's comments. See Greaney, supra note
19, at 663 ("The Seventh Circuit's dismissive analysis of [Schachar's] antitrust claim is
questionable.... ")
104. See Koefoot v. American College of Surgeons, 610 F. Supp. 1298, 1303 (N.D.
Ill.
1985) (The ACS stated that "[i]f Dr. Koefoot chooses not to drive 20 miles to [plaintiff
hospitals] to see his patients, if Dr. Koefoot disagrees with the College's policy, or if Dr.
Koefoot chooses to spend his time on pursuits other than surgery, that is his perfect right.
But he may not call himself a Fellow of the American College of Surgeons."). See supra
section I.A.
105. A standard that operated much like the one in Koefoot was at issue in Wilk
v. American Medical Ass'n, 719 F.2d 207 (7th Cir. 1983), cert. denied, 467 U.S. 1210
(1984), decision on remand, 671 F. Supp. 1465 (N.D. Ill. 1987), aff'd, 895 F.2d 352 (7th
Cir. 1990), cert. denied, 496 U.S. 927 (1990). The AMA's standard prohibited its members
from practicing in association with chiropractors. 719 F.2d at 213-14. Although, as in
Koefoot, an AMA member physician need only have left the society to practice as she
liked, the Wilk court had no difficulty finding a coercive effect. On'remand, it enjoined
the AMA from "restricting, regulating or impeding, or aiding and abetting others from
restricting, regulating or impeding, the freedom of any AMA member or any institution
or hospital to make an individual decision as to whether or not [to] professionally associate
with chiropractors." 671 F. Supp. at 1507.
106. Schachar, 870 F.2d at 399 (citing National Soc'y of Professional Eng'rs, Inc.
v. United States, 435 U.S. 679 (1978); Wilk v. American Medical Ass'n, 719 F.2d 207
(7th Cir. 1983), cert. denied, 467 U.S. 1210 (1984); Moore v. Boating Indus. Ass'ns, 819
F.2d 693 (7th Cir. 1987); Hydrolevel Corp. v. American Soc'y of Mechanical Eng'rs, 635
F.2d 118, 124-27 (2d Cir. 1980), aff'd on other grounds, 456 U.S. 556 (1982); Indian
Head, Inc. v. Allied Tube & Conduit Corp., 817 F.2d 938, 946-47 (2d Cir. 1987), aff'd
on other grounds, 486 U.S. 492, 499 n.3 (1988)).
107. See, e.g., American Soc'y of Mechanical Eng'rs v. Hydrolevel Corp., 456 U.S.
556, 559 (1982) ("These codes, while only advisory, have a powerful influence ....");
Wilk v. American Medical Ass'n, 719 F.2d 207, 230 (7th Cir. 1983) ("[E]ven without
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Moreover, the Supreme Court has repeatedly found antitrust violations
by professional societies in the absence of coercive enforcement, so it
is clear that antitrust liability does not require that there be any formal
enforcement mechanism. 08 It is true that the Court has also said that
"[c]oncerted efforts to enforce (rather than just agree upon) private
product standards face more rigorous antitrust scrutiny."' x 9 But this
merely indicates that the mechanism by which standards act is relevant;
it does not suggest that the Court would exempt from scrutiny standards
that lack formal enforcement. Thus, neither the antitrust laws nor the
Supreme Court's interpretation of those laws imposes a requirement that
a restraint of trade be formally coercive. It is the practical effects of
a standard that matter. 10
Actually, this seems to be acknowledged in Schachar. After Judge
Easterbrook's rhetorical flourish regarding coercion, he evaluated whether
the Academy's action produced anticompetitive effects. As evidence of

coercive enforcement, a court may find that members of an association promulgating
guidelines sanctioning conduct in violation of § 1 participated in an agreement to engage
in an illegal refusal to deal."), cert. denied, 467 U.S. 1210 (1984); see also United States
v. National Soc'y of Professional Eng'rs, Inc., 389 F. Supp. 1193, 1200 (D.D.C. 1974)
(stating that the society "actively pursue[ld] a course of policing adherence" to its ban
on competitive bidding, but referring only to "educational campaigns and personal admonitions to members and clients"), aff'd in part, modified in part on other grounds,
555 F.2d 978 (D.C. Cir. 1977), aff'd, 435 U.S. 679 (1978). In addition, Judge Easterbrook
described the enforcement mechanism in Allied Tube as an agreement "not to manufacture,
distribute, or purchase certain types of products." Schachar, 870 F.2d at 399 (quoting
Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 500 (1988)). But no
evidence was offered in Allied Tube of any efforts to enforce such an agreement. A
competitor was free to manufacture any product it chose; it would just be unable to sell
it due to the established standard labelling it unacceptable. The situation is thus exactly
analogous to that in Schachar, where the resolutions of the medical societies required
members to 'refrain from participating in [radial keratotomies] outside the framework
of [the PERK study]."' Vest v. Waring, 565 F. Supp. 674, 680 n.9 (N.D. Ga. 1983)
(quoting resolution of the New Mexico Ophthalmological Society).
108. For example, the defendant bar association in Goldfarb v. Virginia State Bar,
421 U.S. 773 (1975), set fee standards that it argued were voluntary, so that there was
no real price-fixing. Id. at 781. But the Court responded that the standards presented
not only the threat of professional discipline but "the desire of attorneys to comply with
announced professional norms." Id. (citation omitted). Thus, the Court seemed to say
that any norm issued by a professional society would be a restraint that could create
antitrust liability, merely because the society's members tended to follow it.
109. Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 501 n.6
(1988) (citations omitted, emphasis in original).
110. See Eastman Kodak Co. v. Image Technical Servs., Inc., 112 S. Ct. 2072,
2082 (1992) ("Legal presumptions that rest on formalistic distinctions rather than actual
market realities are generally disfavored in antitrust law. This Court has preferred to
resolve antitrust claims on a case-by-case basis, focusing on the 'particular facts disclosed
by the record."' (citations omitted)).
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a lack of such effects, he pointed out that radial keratotomies continued
to be performed. But this point is hardly conclusive. The Sherman Act
proscribes not just total elimination of trade, but all unreasonable restraint of trade."' In fact, the court went on to discuss the number of
radial keratotomies that were performed, indicating that it acknowledged
the number's relevance. It should, therefore, have considered the extent,
2
if any, of the reduction in the number of radial keratotomies performed."
Reduced output is what antitrust law is all about.
B.

Medical Society Power in the Market for Information

The misplaced emphasis on coercion is a result of a misconception
regarding the nature of medical societies' market power. Coercion of
society members is a product of the power of societies to grant or deny
membership. If a society, as in Koefoot, denied membership to those
who did not conform to its standards, it might be able to force its
members to conform. It is true that some society power is of this kind
and derives from the importance to individual professionals of society
membership. Membership provides a source of referrals,"' and it may
be useful for marketing one's services. It may even be necessary to
qualify for staff privileges in a hospital." 4 But it is not this sort of
power in the professional employment market that is reflected in Schachar
and to a large extent in Koefoot.
In those cases, competitive effects were produced by society influence
over third parties, i.e., patients and insurers, rather than society members.
That influence was produced by the evaluations communicated in the
societies' statements: in Koefoot, labelling itinerant surgery "unethical,"" 5 and in Schachar, labelling radial keratotomy "experimental" and
6
saying it should not be performed outside a particular research study."

See supra note 9.
112. That was the approach taken by the Supreme Court in Goldfarb, where it
pointed out that every lawyer that the petitioners had contacted had adhered to the fee
schedule, which it said "reveal[ed] a situation quite different from what would occur
under a purely advisory fee schedule." Goldfarb, 421 U.S. at 781. Thus, the Court
expressed its willingness to rely on the effects of a society's standards as evidence of their
coercive power. It made this approach more explicit in FTC v. Indiana Fed'n of Dentists,
476 U.S. 447 (1986), where it noted the FTC's finding that the federation's restrictions
were adhered to by its members and said that those effects were "legally sufficient to
support a finding that the challenged restraint was unreasonable." Id. at 461.
113. Kreuzer v. American Academy of Periodontology, 735 F.2d 1479, 1484 (D.C.
Cir. 1984).
114. Koefoot v. American College of Surgeons, 610 F. Supp. 1298, 1301 (N.D. Ill.
111.

1985).
115.
116.

See supra section I.A.
See supra section I.B.
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In a very real sense, therefore, the societies' influence was caused by
their power in a market for medical information."17 Although neither
consumers nor (usually) third-party payers actually purchase medical
information directly, both actively seek it out. Professional societies
willingly respond by supplying this information. Indeed, professional

societies are major suppliers in the medical information market.' For
better or worse, their prominent positions in their fields, and the respect
and esteem in which they are held, give them power in that market." 9

Moreover, it is difficult for new entrants to attain comparable positions
in order to provide alternative views regarding medical services.'n
As was made clear in Koefoot and Schachar,the medical information
market has strong effects on the medical services market. The exact
mechanism of these effects can be described in any of several ways, 21

117. The same observation has been made in the context of medical credentials and
accreditation: "The key to the analysis-and the shortest and surest path to sensible legal
results-is recognition that a market for commercially valuable information and opinion
exists and can be kept competitive by applying traditional antitrust principles to those
participating in it." Havighurst & King, supra note 4 (pt. 2), at 334. See also Howard
Beales, Richard Craswell, & Steven C. Salop, The Efficient Regulation of Consumer
Information, 24 J. L. & EcoN. 491, 505 (1981) ("When scale economies in information
generation and dissemination lead to natural monopoly problems, information intermediaries
can achieve a high level of market power, though it may not be exercised in practice.").
118. See Havighurst, supra note 18, at 350 ("Much of the privately generated
information concerning medical technology emanates from professionals and professional
organizations.").
119. See, e.g., Schachar v. American Academy of Ophthalmology, Inc., 1988-1
Trade Cases (CCH) 67,986, at 58,052 (N.D. IIl.) ("The views of [a large and highly
respected professional] organization specializing in a field about which the general public
is generally uninformed, especially where the views are publically disseminated to potential
patients and third party payers, acquire significantly more weight and thus have a more
coercive effect than would the views of individuals.").
120. See Havighurst, supra note 18, at 350 ("Because of the difficulties of marketing
public goods .... private technology assessment is more likely to be undertaken by large
organizations that can themselves internalize enough of the benefit to justify the cost.").
121. For example, one can look at the effect of standards from the perspective of
purchasers of medical services. For such a group, standards greatly affect information
costs. See Eastman Kodak Co. v. Image Technical Servs., Inc., 112 S. Ct. 2072, 208587 (1992) (discussing effects of information costs generally). The relative availability of
information regarding different medical services, and the nature of that information, will
be largely a function of the standards and statements that have been issued regarding
those services. Therefore, because information about medical services is difficult and costly
to obtain, when a standard is available it is likely to be the only information a consumer
will use. See id. at 2086 ("[E]ven if consumers were capable of acquiring and processing
the complex body of information, they may choose not to do so. Acquiring the information
is expensive.").
Imposing liability on competitors who worsen this problem has been considered. In
Town Sound and Custom Tops, Inc. v. Chrysler Motors Corp., 959 F.2d 468 (3d Cir.
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but the important point is that information (or misinformation) conveyed

1992), cert. denied, 113 S. Ct. 196 (1992), the plaintiff argued that Chrysler's policy of
requiring consumers to purchase radios with its cars allowed it to include part of the
price of the radios in the base price of the car, thus misleading consumers regarding the
price that they were paying for the radios. The court agreed that "[a]ctions creating or
exacerbating problems of imperfect information could be seen as 'restraining trade' or
'substantially lessening competition' even though not leading to monopoly or oligopoly."
Id. at 492 n.34. The court also noted that some comments in the Supreme Court's opinion
in Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2 (1984), might justify such a
view. 959 F.2d at 490-92. But it declined to consider that option itself, "absent a much
clearer mandate from the Court." Id. at 492. Kodak may be that mandate. In any event,
Chrysler's actions in Town Sound were not specifically directed at conveying information.
In professional standard-setting, where informing others is the goal of the actions at issue,
more searching scrutiny is appropriate.
Alternatively, one can look at the costs of the suppliers who compete with standardsetters. Although in principle it is possible for competing suppliers to correct misleading
information conveyed by a standard, so as to recover the demand of consumers, it may
be prohibitively expensive to do so. See Kodak, 112 S. Ct. at 2086 n.21 ("Even in a
market with many sellers, any one competitor may not have sufficient incentive to inform
consumers because the increased patronage attributable to the corrected consumer beliefs
will be shared among other competitors." (citation omitted)). And even if a supplier did
expend the resources to compete against a misleading standard, doing so would raise his
costs, and, therefore, disadvantage him in competition. This occurred in Interstate Circuit,
Inc. v. United States, 306 U.S. 208 (1939). The defendant in Interstate Circuit, a monopoly
operator of first-run movie theaters, prevailed upon a distributor to require second-run
theaters to charge a minimum price. Id. at 215-18. As Professors Krattenmaker and Salop
point out, the effect of this action was to raise the costs of the second-run theaters: "The
price that theaters paid for exhibition rights did not necessarily rise but, presumably, their
costs of attracting patrons did." Thomas G. Krattenmaker & Steven C. Salop, Anticompetitive Exclusion: Raising Rivals' Costs to Achieve Power over Price, 96 YALE L.J. 209,
239 n.97 (1986). The necessity of competing with a deceptive standard imposes similar
additional costs on competitors of the standard-setters. Professors Krattenmaker and Salop
note that under these circumstances the theory that monopoly power in one market (i.e.,
medical information) can be "leveraged" into another (i.e., medical services) is plausible.
Id. at 248-49.
Interestingly, both of these mechanisms were discussed in a recent article on professional rules, yet the author of that article had little concern regarding the demandrelated effects described here. See John E. Lopatka, Antitrust and ProfessionalRules: A
Framework for Analysis, 28 SAN Dmoo L. R-v. 301 (1991). Professor Lopatka describes,
in a discussion emphasizing economic theory, how restrictions in the supply of information
can both increase consumer search costs, id. at 317-23, and raise the costs of providers,
id. at 323-32. He further notes the parallels between these two phenomena and observes,
as does this Article, that "[t]he best way to view the matter may be to recognize a
demand for information." Id. at 329. Nevertheless, when he discusses what he calls the
"theoretical possibility" of a group of professionals collusively manipulating demand by
establishing rules that mislead consumers, he states only that "determining that such a
rule is likely to reduce welfare would be difficult." Id. at 333-35.
Professor Lopatka does not apply his observations on cost-raising to the manipulation
of demand by professionals because he focuses only on markets defined by professional
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in society standards, and the interpretation of that information by its

recipients, influences the purchase of medical services. The influence is
effective independent of any influence or coercion that societies impose

on their members. This has two important implications. First, the cases
that look at the percentage of physicians belonging to a society' 2 or at

the importance to a physician of belonging to a society' 3 are missing
the point. Those factors affect only the society's power in the market
for medical society membership, not necessarily its power in the medical
services market. 1 4 Second, and conversely, a society's power to affect

services as a whole, rather than on particular product markets. For example, although
Professor Lopatka notes that his model of increased consumer costs "depends on a change
in demand, not a change in the costs of the supplies," id. at 321, he examines this
phenomenon only in the context of the suppression of price information, an action that
affects the entire professional services market. See id. at 318-21. Similarly, in describing
the efforts of dentists who do not use dental hygienists to raise their rivals' costs by
banning those rivals' use of hygienists, he notes only that "[t]he industry supply curve
rotates up and to the left." Id. at 324. The industry focus of Professor Lopatka is
confirmed by his statement dismissing the importance of professional rules affecting
information: "The information restrained by such a rule might have no effect on the
demand for professional services, but merely cause a shift in the pattern of supply among
professionals." Id. at 334. But it is exactly control over the shifting of supply patterns
(that is, the allocation of productive capacity) that the antitrust laws seek to prevent.
See, e.g., I PHUniw AREEDA & DONALD F. TURNER, ANrrRusr LAw
103 (1978) ("The
economic objective of a pro-competitive policy is to maximize consumer economic welfare
through efficiency in the use and allocation of scarce resources .... "). A focus on an
entire industry is only appropriate when the cross-elasticity of demand among the various
services in that industry is high. See generally 2 PHLip AREEDA & DoNALD F. TURNER,
ANTTRusT LAW
525 (1978). That is, it is only appropriate when consumers perceive
the services in the industry as close substitutes. Id. This may be the case in Professor
Lopatka's examples. For instance, consumers are probably largely indifferent between
dental-services-without-dental-hygienists and dental-services-with-dental-hygienists. However, in many other cases, consumers are not indifferent between professional services.
In the ophthalmological area, for example, consumers do not treat even contact lenses
and eyeglasses as completely interchangeable, and it is not likely that a surgical procedure
like radial keratotomy would be perceived as a close substitute for either. Therefore,
radial keratotomy probably constitutes an market in itself, and the effects of manipulation
of demand should be assessed in that market, not in the market for ophthalmological
(or, even more broadly, medical) services in general. The same anticompetitive potential
that Professor Lopatka describes for entire industries also applies to individual product
markets.
122. See, e.g., Schachar, 1988-1 Trade Cases (CCH)
67,986, at 58,050 (noting
that over ninety percent of all ophthalmologists in the United States belong to the American
Academy of Ophthalmologists).
123. See supra text accompanying notes 113-14.
124. Of course, the importance of society membership and power in the information
market will often both be present when a society is prominent and well respected. But
power in the information market does not derive from the importance of membership;
instead, both are a result of the prominence of the society.
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the consumption of medical services may be much greater, due to the
esteem in which it is held or the effectiveness of publication of its
statements, than its size or market share of physicians would predict. '1
The Supreme Court has recognized exactly this sort of market power
in two trade association cases. In American Society of Mechanical Engineers v. Hydrolevel Corp. ,126 for example, it said that the society's
"agents exercise economic power because they act with the force of the
Society's reputation behind them."127 That power derived not from
influence over the members of the society, but because the Society's
"codes and standards influence the policies of numerous States and
cities, and, as has been said about 'so-called voluntary standards' generally, [the Society's] interpretation of its guidelines 'may result in economic prosperity or economic failure for a number businesses of all
sizes throughout the country,' as well as entire segments of an industry.' ' 2 Similarly, in Allied Tube & Conduit Corp. v. Indian Head,
Inc.,129 the Court said that it was deciding the case "on the theory 'that
the stigma of not obtaining [Code] approval of its products and [the
defendant's] "marketing" of that stigma caused independent marketplace
harm' to the plaintiff." 0 The "independent marketplace harm" produced
by the absence of Code approval was a result of the standard's impact
on third parties, not its effect on society members. 3 '

125. Cf. Mozart Co. v. Mercedes-Benz of North America, Inc., 833 F.2d 1342,
1346-47 (9th Cir. 1987) (pointing out that although the uniqueness of Mercedes automobiles
may provide market power in the consumer market, it does not necessarily do so in the
dealer market for automobile franchises), cert. denied, 488 U.S. 870 (1988).
126. 456 U.S. 556 (1982).
127. Id.at 574.
128. Id. at 570 (quoting H.R. Rep. No. 1981, 90th Cong., 2d Sess. 75 (1968)).
129. 486 U.S. 492 (1988).
130. 486 U.S. at 498 n.2 (quoting Indian Head, Inc. v. Allied Tube & Conduit
Corp., 817 F.2d 938, 941 n.3 (2d Cir. 1987), with interpolations by Supreme Court); see
also Koefoot v. American College of Surgeons, 610 F. Supp. 1298, 1308 (N.D. Il.1985)
("[T]his Court simply cannot accept the defendants' contention that any injury to Dr.
Koefoot's reputation is irrelevant to his antitrust claim. To the extent that the number
of patients referred to a surgeon depends on his reputation, that reputation is critically
important and directly affects his income. Because Dr. Koefoot is a direct competitor of
surgeons who are Fellows of the American College of Surgeons, injury to his reputation
and income is precisely the sort of anti-competitive injury that the antitrust laws were
designed to prevent.").
131. It should be pointed out that at another point the Allied Tube Court said
that the effects of the code were not solely a result of the "power of persuasion." It
noted that "[t]he Association's members, after all, include consumers, distributors, and
manufacturers of electrical conduit, and any agreement to exclude [a particular product]
from the Code is in part an implicit agreement not to trade in [the product]." 486 U.S.
at 507. The presence of consumers in a trade association, when the association takes a
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C. Competitive Effects in the Medical Information Market
Accepting that medical societies influence the operation of the medical
services market by issuing evaluations of products and services to third
parties, how does that information affect competition? Third-party payers, as discussed below,' 32 present a special case because they often
respond not to the information in a standard but merely to the fact of
its issuance. For consumers, it is the specific statements of the society
that affect their decisions. Therefore, as the Supreme Court has said in
addressing this issue, it is important that "private economic decisions
...be intelligent and well informed."' 33 The focus should be on whether
the information provided enables patients to make better, i.e., better
informed, choices of services.' 3 4 In other words, do the medical societies
provide accurate information, or do they 35merely (mis)lead patients to
purchase the services the societies prefer?'
There are two ways to attempt to ensure that information flows
cleanly and accurately: information can be tested for substantive content,
or the generation of information can be governed by rules that ensure
the integrity of the information-generating process. The Supreme Court
in Allied Tube relied on both tests in stating its view that if private
position disapproving a product, lends the association's action the character of a group
boycott. See Havighurst & King, supra note 4 (pt. 1), at 173-74. Because professionals
societies do not have patients as members, they do not share this problem.
132. See infra section III.B.
133. Virginia State Bd. of Pharmacy v. Virginia Citizens Consumer Council, Inc.,
425 U.S. 748, 765 (1976).
134. See Havighurst, supra note 18, at 350 ("[T]he issue that antitrust courts must
resolve is whether professional sponsorship of technology assessment perpetuates professional dominance, thus impeding rather than promoting the movement toward a competitive
market in which choices are made, with good information, by consumers and independent
agents acting on their behalf.").
135. The staff of the Federal Trade Commission has described a variety of ways
in which standards can be deceptive or misleading. See BUREAU OF CONSUMER PROTECTION,
FEDERAL TRADE COMESSION, STANDARDS AND CERTIFICATION: FINAL STAFF REPORT 188209, 288-95 (1983). As described in notes 152 and 218 infra, the F.T.C. proposed regulations
in this area, but its authority to issue such regulations was withdrawn by Congress with
the comment that deceptive standards were already prohibited by the antitrust laws.
At least one court of appeals has appeared to accept this theory of competitive
impact, at least in principle. In Clamp-All Corp. v. Cast Iron Soil Pipe Inst., 851 F.2d
478 (1st Cir. 1988), cert. denied, 488 U.S. 1007 (1989), the plaintiff alleged that the form
of a trade association's standard might have misled users regarding the significance of
the association's approval. The court affirmed a finding of no antitrust liability because
there was "no testimony that any of [the consumers] was fooled." Id. at 487-88. It did
not, however, reject the argument that such deception could be anticompetitive. See id.
For a similar view in a somewhat different context, see the discussion of Town Sound
and Custom Tops, Inc. v. Chrysler Motors Corp., 959 F.2d 468 (3d Cir. 1992), cert.
denied, 113 S.Ct. 196 (1992), in note 121 supra.
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standards are derived "based on the merits of objective expert judgments
and through procedures that prevent the standard-setting process from
being biased by members with economic interests in stifling product
competition, those private standards can have significant procompetitive
advantages."'13 6 However, despite this statement's reference to both substantive and procedural tests, the rest of the case focused solely on the
procedural protections.
Allied Tube involved the National Fire Protection Association (NFPA),
which sets and publishes standards routinely adopted as law in many
jurisdictions. 137 A change was proposed to a standard established by the
NFPA, and the standard's supporters (most of whom were manufacturers
of products that conformed to it) packed the association's annual meeting
with new members recruited specifically to vote against the proposed
change, which would have approved a new and competing product. 3 '
The change was voted down. 1 9 The Court said that even though the
packing of the meeting did not actually violate the association's rules,
and even though most of the damage to plaintiffs was done by government
adoption of the NFPA's standards, the association was responsible for
seeing that its power was not used in such a fashion:
[T]he hope of procompetitive benefits depends upon the existence
of safeguards sufficient to prevent the standard-setting process
from being biased by members with economic interests in restraining competition. An association cannot validate the anticompetitive activities of its members 40simply by adopting rules
that fail to provide such safeguards.

It is not clear, however, that there could ever be procedural safeguards
sufficient to protect the standard-setting process from economic selfinterest. The problem is especially acute in a case like Wilk v. American
Medical Association,14' where the American Medical Association sought
to "eliminate" the practice of chiropractic, in part through enactment
of an "ethical principle" that prohibited its members from practicing
in association with chiropractors. 42 In that case, where the disapproved

136.

Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 501 (1988)

(citation omitted).
137. Id.at 495-96.
138. Id. at 496-97.
139. Id. at 497.
140. Id. at 509 (footnote omitted).
141. 719 F.2d 207 (7th Cir. 1983), cert. denied, 467 U.S. 1210 (1984), decision on
remand, 671 F. Supp. 1465 (N.D. Ill.
1987), aff'd 895 F.2d 352 (7th Cir. 1990), cert.
denied, 496 U.S. 927 (1990).
142. Until 1980, Principle 3 of the American Medical Association (AMA) Principles
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practitioners (i.e., the chiropractors) were not members of the society
issuing the standard, it was arguably in every society member's selfinterest to pass a restrictive standard. Even when society members disagree
about a standard, presumably the best that can be done is to determine
whether it is preferred by a majority of society members. Enactment
of such a standard would still not meet antitrust requirements, for two
reasons.
First, any new practice technique adopted by professionals is introduced first by a minority of professionals. There is no reason to suppose
that these innovative professionals are less able than others to determine
whether the new technique is safe. To the contrary, their experience
with the new technique places them in the best position to evaluate it.'14
Furthermore, it is possible, if not likely, that those professionals not
yet practiced in the new technique will be suspicious of it.14 Therefore,
given the uncertainty in evaluating any medical technique, a majority
(or even super-majority) vote is likely to reject most new techniques,
regardless of merit.
Second, and more important, the antitrust laws do not operate by
majority vote of producers, but by the market decisions of consumers.
One could certainly adopt the position that, given safety concerns, new
procedures should be adopted only when a majority of professionals
approve them, but that is not the position adopted by the Sherman Act.
The Supreme Court has never said that the choice in these matters
should not. remain with consumers. It is especially unlikely that the

Court would allow a group of producers to decide on the proper form
of services to provide to consumers. In National Society of Professional
Engineers v. United States,'45 the Court said that, even in the absence
of a professional society's quality standards, quality goods could still
be produced because "a purchaser might conclude that his interest in
quality-which may embrace the safety of the end product-outweighs

of Medical Ethics provided: "A physician should practice a method of healing founded
on a scientific basis; and he should not voluntarily professionally associate with anyone
who violates this principle." 719 F.2d at 231. The AMA at the time considered chiropractic
unscientific, and its official interpretation of Principle 3 described it as such, so Principle
3 discouraged physicians from associating with chiropractors. Id.
143. This is not to say that such groups will not have their own bias, probably in
favor of the new technique, or that they are the only ones who should be able to evaluate
it. The point is just that, given their experience with the technique, their views are likely
to be well informed and should not be permitted to be overwhelmed by the majority's
less informed perceptions. To the extent that the innovators made deceptive statements
regarding the technique, though, they would be liable on the same terms as the larger
group (assuming that they too had market power). See infra section III.A.
144. See supra note 15.
145. 435 U.S. 679 (1978).
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the advantages of achieving cost savings by pitting one competitor against
another."'' The choice, therefore, should remain with consumers. When
the profession restricts the consumer's options by imposing norms for
the behavior of its members, it "imposes the Society's views of the costs
and benefits of competition on the entire marketplace."' 47 Similarly, the
Court in FTC v. Indiana Federation of Dentists'" said that "[a] refusal
to compete with respect to the package of services offered to customers,
no less than a refusal to compete with respect to the price term of an
agreement, impairs the ability of the market to advance social welfare.' 1 49
The Court again emphasized its concern that consumers have free choice:
"The Federation is not entitled to pre-empt the working of the market
by deciding for itself that its customers do not need that which they
demand." 150
These statements suggest that Allied Tube's emphasis on procedural
protections was due more to the actions of the defendant to 'subvert'
the consensus standard making process" ' than to any unwillingness of
the Court to impose substantive requirements.5 2 Procompetitive standards

146. Id. at 694.
147. Id. at 695.
148. 476 U.S. 447 (1986).
149. Id. at 459.
150. Id. at 462. The Court was actually somewhat equivocal on this question in
Indiana Federation of Dentists. When the federation attempted to use patient care as its
justification for declining to provide x-rays to insurers, the Court rejected the justification
because it was unsupported by any evidence that consumers had in fact been harmed. It
did not rule out a patient-care defense entirely, though, resting its decision on the facts
of the case "even if concern for the quality of patient care could under some circumstances
serve as a justification for a restraint of the sort imposed." Id. at 464. But the Court
has since categorically rejected a quality-of-care argument in another case involving the
medical profession (though not a professional society). In Jefferson Parish Hosp. Dist.
No. 2 v. Hyde, 466 U.S. 2 (1984), the plaintiff anesthesiologist claimed that a hospital's
contract with a single anesthesiology group was an illegal tie-in. The Court rejected the
claim, but said in a footnote that if there had been evidence of an illegal tying arrangement,
the reasons for its creation would have been irrelevant. The Court "reject[ed] the view
of the District Court that the legality of an arrangement of this kind turns on whether
it was adopted for the purpose of improving patient care." Id. at 25 n.41.
151. Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 498 (1988).
152. As described in note 218 infra, the staff of the Federal Trade Commission in
1978 proposed substantive rules to prevent deception of consumers by standards, but
Congress withdrew the F.T.C.'s rule-making authority in this area. Following Congress's
action, the F.T.C. staff issued a final rule proposal that mandated only procedural processes

for complaint handling by standards organizations. See BUREAU OF CONSUMER PROTECTION,
FEDERAL TRADE COMMIISSION, STANDARDS AND CERTIFICATION: FINAL STAFF REPORT 33944 (1983). In the end, even that rule was not issued, because the Commission decided to
use case-by-case enforcement in situations of anticompetitive standard-setting. See 50 Fed.
Reg. 44,971 (1985). The Commission noted that it made that decision in part because the
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should therefore be required to meet a substantive test like the one
expressed in that case, where the Court said that standards should be
based on "objective expert judgments." 153 Only then will the standards
promote, rather than hinder, the workings of the market. This test,
however, immediately raises the question of a conflict between the
antitrust laws and the First Amendment. Are professional societies not
free, as Judge Easterbrook says, 154 to speak out regarding their services
regardless of whether their statements are false or misleading? The answer,
as the following section shows, is no.
D.

The Antitrust Laws and Speech

The Sherman Act is, of course, subject to the limitations of the
Constitution. Part of that limitation is the First Amendment's protection
of freedom of speech, which must be considered in enforcing the antitrust
law. But a group cannot merely point to the First Amendment to
immunize speech that restrains trade:
[I]t has never been deemed an abridgment of freedom speech
or press to make a course of conduct illegal merely because the
conduct was in part initiated, evidenced, or carried out by means
of language, either spoken, written, or printed .... Such an
expansive interpretation of the constitutional guaranties of speech
and press would make it practically impossible ever to enforce
laws against agreements in restraint of trade as well as many
other agreements and conspiracies deemed injurious to society. 55
The interrelationship of the antitrust laws and the First Amendment has
been explored almost exclusively in the context of "political" speech.
The two areas of law have been reconciled in the development of the
Noerr-Penningtondoctrine, 5 6 which provides immunity from the antitrust
laws for speech addressed to the government. Such speech, and other
activities seeking government action, are protected even if the activities

anticompetitive dangers presented by standards had decreased as a result of changes in
standards organizations' procedures following a Supreme Court decision that imposed
liability on a standard-setting society for the anticompetitive activities of its members. Id.
The decision to which the Commission referred was presumably American Soc'y of
Mechanical Eng'rs, Inc. v. Hydrolevel Corp., 456 U.S. 556 (1982), which is discussed in
note 190 infra.
153. Allied Tube, 486 U.S. at 501.
154. See supra text accompanying note 102.
155. California Motor Transport Co. v. Trucking Unlimited, 404 U.S. 508, 514
(1972) (quoting Giboney v. Empire Storage Co., 336 U.S. 490, 502 (1949)).
156. The application of the Noerr-Pennington doctrine to society standards is discussed in more detail in section IV.C infra.
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are motivated by an anticompetitive purpose. But even this First Amendment protection is limited, and the nature of the limitation sheds light
on the permissible boundaries for standard-setting.
Noer-Pennington immunity has been held by the Supreme Court not
to extend to misrepresentations or fraud, at least in forums less political
15 7
than the legislature, such as the courts and administrative agencies.
Significantly, the Court in Allied Tube focused on this exception in
denying Noerr-Penningtonimmunity in that case.15 The Court reaffirmed
the exception to immunity for deceptive speech before courts and administrative agencies, and even suggested, contrary to previous cases,
that it might extend to some legislative bodies. 5 9 The Court then made
clear that deceptive speech is also unprotected in the private context. It
observed that because private standard-setting involves collaboration among
business competitors, "the standards of conduct in this context are, at
least in some respects, more rigorous than the standards of conduct
prevailing in the partisan political arena or in the adversarial process
of adjudication.2'160
Thus, Allied Tube shows little tolerance for deception in the standardsetting process. The Court's focus, however, was on proceedings before
the standard-setting body, not on the standards as they were addressed
to the public.' 61 Therefore, Allied Tube does not necessarily show that
the Court's concern for substantive accuracy extends to speech directed
outside the organization 62 As it happens, a demand for accuracy from

157. California Motor Transport Co., 404 U.S. at 510-13.
158. The defendants there argued that, because their standards were enacted into
law by many local governments, their standard-setting efforts were "quasi-legislative."
The Court disagreed: "That rounding up supporters is an acceptable and constitutionally
protected method of influencing elections does not mean that rounding up economically
interested persons to set private standards must also be protected." Allied Tube & Conduit
Corp. v. Indian Head, Inc., 486 U.S. 492, 504 (1988).
159. Id. at 500 (citing California Motor Transport Co. v. Trucking Unlimited, 404
U.S. 508, 512-13 (1972)); id. at 504 (suggesting that "misrepresentations made under oath
at a legislative committee hearing" would not be protected).
160. Id. at 507.
161. See supra text accompanying notes 138-41.
162. At least one case suggests that the Court's standards for speech to the public
would be at least as strict as those for speech within the organization. In Noerr itself,
where a group of railroads were seeking legislative action to disadvantage the trucking
industry, the railroads also engaged in a campaign to persuade the public to support its
legislative efforts. Eastern R.R. Presidents Conference v. Noerr Motor Freight, Inc., 365
U.S. 127, 142-44 (1961). The Court specifically noted though, that to the extent the
truckers suffered injury as a result of the publicity campaign, the injury was only incidental
to the railroads' efforts seeking legislative action. Id. at 143. It said that "[there [were]
no specific findings that the railroads attempted directly to persuade anyone not to deal
with the truckers." Id. at 142. Therefore, in a case like Schachar, where the societies
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groups of professionals is supported by another line of Supreme Court
cases that requires such accuracy from individual professionals.
Individual professionals often make advertising claims for their services not unlike the claims of professional societies. In the cases described
below, such advertising claims were challenged by professional societies
as violations of their codes of ethics. Because many of these professional
organizations, such as bar associations, are state agencies, their restrictions on members' speech are subject to the First Amendment. That is,
professional societies' rules regarding members' speech are subject to
much the same limitations as is antitrust regulation of the societies'
speech. Therefore, the Court's treatment of these cases should provide
insight into its views on collective professional speech as well.
In applying the First Amendment to professional advertising, the
Court has moved from an initially broad protection of speech to an
emphasis on accuracy that recognizes the element of trade regulation in
these cases. 63 The evolution began in Virginia State Board of Pharmacy
v. Virginia Citizens Consumer Council; Inc.,164 where the Supreme Court
held that the First Amendment protected the advertisement of drug prices
by pharmacists. In this case, there was no question of the advertisements'
accuracy, so the Court saw no reason to restrict them. It said, for
example, that the state-imposed restrictions rested on the assumption
that there were benefits from keeping the public in ignorance. 165 However,
the Court recognized that commercial speech must be judged by its
commercial impact. It said that "proper allocation of resources in a
free enterprise system" depends on the flow of information about the
operation of that system.'6 Accordingly, the Court said that if the state
had chosen only to restrict "false or misleading" speech, the First
Amendment would not have been an obstacle. 167 The majority did not

specifically sought to influence the public not to receive radial keratotomies outside their
own studies the Court would likely interpret the societies' First Amendment protections

narrowly.
163. Consider, for example, Ohralik v. Ohio State Bar Ass'n, 436 U.S. 447 (1978),
where the Court rejected an attorney's argument that his in-person solicitation of potential
clients was protected by the First Amendment. The conduct is barely acknowledged to

have a speech component at all-the Court says that it is "only marginally affected with
First Amendment concerns" and compares it to direct selling techniques regulated by the

Federal Trade Commission. Id. at 459, 464-65. See also C. Lee Peeler & Michelle K.
Rusk, Commercial Speech and the FTC's Consumer Protection Program, 59 ANTrrRUST
L. J. 985 (1991) (describing compatibility between the Supreme Court's protection of
commercial speech and the FTC's prohibition of deceptive advertising).
164. 425 U.S. 748 (1976).

165. Id. at 769-70.
166. Id. at 765.
167.

Id. at 771-72. The Court said that, given both the verifiability provided by
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elaborate on this conclusion, but Justice Stewart, concurring, drew an
analogy to the speech of employers in labor relations, which must "be
carefully phrased on the basis of objective fact" and must avoid conscious
overstatement. 16 He emphasized that when the speaker has "specific
and unique knowledge of the relevant facts," she has a special obligation
to avoid false or misleading speech. 16 9
This concern regarding specialized knowledge came to the fore in
Bates v. State Bar of Arizona,'70 which followed Virginia Board of
Pharmacy in upholding advertising of routine legal services. 1 7' In doing
so, Bates made some observations that are particularly relevant to professional standard-setting. Most importantly, it expressed concerns regarding claims of quality, and made clear that it would examine them
closely. 7 2 It said, for example, that "because the public lacks sophistication concerning legal services, misstatements that might be overlooked
or deemed unimportant in other advertising may be found quite inappropriate in legal advertising."' 7 Two dissenting opinions would have
gone further and rejected any First Amendment protection for the advertising, on the grounds that legal services are too individualized to be
susceptible to non-misleading advertisement of prices. 7 4
The implications of these statements in Bates are as yet unclear,
because the Court has not yet addressed a case in which claims of
quality have been made. 175 The closest it has come are two additional
cases involving lawyer advertising, In re R.M.J.7 6 and Peel v. Attorney

the familiarity of the speaker with his product and the strong commercial motivation for
it, it may be "less necessary to tolerate inaccurate statements for fear of silencing the
speaker." Id. at 772 n.24.
168. Id. at 778-79 (Stewart, J., concurring) (quoting NLRB v. Gissel Packing Co.,
Inc., 395 U.S. 575, 618 (1969)).
169. Id. at 779 (Stewart, J., concurring).
170. 433 U.S. 350 (1977).
171. The Court said that the conclusion in Bates "might be said to flow afortiori"
from that in Virginia Board of Pharmacy. Id. at 365.
172. Id. at 366 ("[Wle need not address the peculiar problems associated with
advertising claims relating to the quality of legal services. Such claims probably are not
susceptible of precise measurement or verification and, under some circumstances, might
well be deceptive or misleading to the public, or even false.").
173. Id. at 383 (footnote omitted); see also Virginia Board of Pharmacy, 425 U.S.
at 773 n.25.
174. 433 U.S. at 386-87 (Burger, C.J., dissenting), 389-96 (Powell, J., dissenting).
175. That is, the Court has not considered a case in which quality claims were the
center of the dispute. It has, of course, considered cases in which quality was used as a
justification for other society actions. See, e.g., FTC v. Indiana Fed'n of Dentists, 476
U.S. 447, 464 (1986); Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2, 25 n.41
(1984); National Soc'y of Professional Eng'rs, 435 U.S. 679, 694 (1978).
176. 455 U.S. 191 (1982).
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Registration and Disciplinary Commission of Illinois. 77 In In re R.M.J.,
a lawyer had advertised that he was "Admitted to Practice Before THE
UNITED STATES SUPREME COURT.' 7 8 The Court said that the
statement "could be misleading to the general public unfamiliar with
the requirements of admission to the Bar of this Court."'7 9 However,
in the absence of findings in the record regarding whether the information
was misleading, the Court allowed the advertising.8 0
In Peel, the Court had the opportunity to consider a similar issue
on a more fully developed record. The petitioner had stated on his
letterhead, truthfully, that he was a civil trial specialist certified by the
National Board of Trial Advocacy ("NBTA"), a private group. The
Illinois attorney disciplinary commission found the advertisement to be
a violation of the state's code of professional responsibility, which
prohibited an attorney from advertising himself as "certified" or as a
"specialist." The Illinois Supreme Court adopted the commission's conclusion. The plurality opinion from the United States Supreme Court
rejected the state court's decision, focusing on the allegedly misleading
nature of the advertisement. The Court concluded that it was not actually
misleading because there was no showing that the advertisement produced
the impression among the public that the certification was by the state,
or that the public was unable to distinguish "between statements of
opinion or quality and statements of objective facts that may support
an inference of quality."' 8' It acknowledged that the advertisement might
be potentially misleading, but said that, even assuming that some might
be misled, the blanket ban on such advertising was broader than reasonably necessary to prevent that danger. 8 2 In drawing these conclusions,
however, the Court observed that the NBTA's "standards ... are
objective and demanding."'' 8 Furthermore, a narrower constraint might
have been permissible. For example, the state could have required that
certification be based on "objective and consistently applied standards"
or that the advertisement include a disclaimer.'8
The plurality's emphasis on the need for objectivity in the advertised
standards highlights the evolution in commercial speech doctrine. The
concern regarding misleading speech has become a dominant issue in
the cases since its passing mention in Virginia Board of Pharmacy. In

177.
178.
179.
180.
181.
182.
183.
184.

496 U.S. 91 (1990).
455 U.S. at 197.
Id. at 205.
Id. at 205-08.
Peel, 496 U.S. at 101.
Id. at 106-10.
Id. at 95.
Id. at 109-10.
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that case, the concern was overridden by the Court's belief that the
market depends on the flow of information about products. In Peel,
the focus has shifted to a concern with market failure due to deceptive
or misleading information. This brings the commercial speech test very
close to the antitrust test for association standards, which, as described
above,"'5 requires that standards be derived "based on the merits of
objective expert judgments."'' 1 6 Thus, Peel gives no reason to believe
that a requirement of accuracy runs afoul of the First Amendment. This
is all the more true because Peel did not involve a true claim of quality.
In contrast, the medical standards at issue in, for example, Schachar,
purport to assess the quality or safety of a particular medical service.
The opportunity for deception with such a claim is, as the Court has
stated, much greater. Hence the Court would probably allow more
regulation of quality claims.
It is true that regulation of professional advertisements that may be
misleading-the commercial speech problem-is significantly different
from imposing antitrust liability, including possible treble damages, for
misleading standards. s7 However, professional disciplinary proceedings
can also impose severe penalties, and the problem of evaluating the
statements in the two cases is similar. Professor Havighurst argues that
professional speech should not be subject to antitrust limitation because
it is difficult for courts to evaluate its accuracy.' 8 But there are several
185. See supra section ILC.
186. Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 501 (1988)
(citation omitted).
187. On the other hand, deceptive standard-setting may present greater dangers than
deceptive advertising. This is true because, as described in the text accompanying notes
41-43 supra, professional standards, unlike most industrial standards, are generally set by
groups with economic interests in the standards. If consumers are unaware of this fact,
and interpret professionals standards as if they were set by disinterested groups, they may
give the standards more credence than they would advertising. On the same problem in
the related area of medical credentials, see Havighurst & King, supra note 4 (pt. 1), at
153 ("Consumers can readily perceive advertising's self-serving character and may consequently greet it with a healthy skepticism. They may be significantly less skeptical toward
personnel credentialing as a result of its apparently objective and authoritative character,
the professional auspices under which credentials are granted, and the typical absence of
competing claims.")
188. His argument emphasizes both theoretical and practical considerations:
Antitrust courts are poorly equipped to evaluate the quality and honesty of
opinions and information generated by professional organizations. By hypothesis,
the issues are highly technical and controversial. Litigation closely examining
the merits of these issues, the circumstances and effects of various pronouncements, the motives of the parties, the honesty of the opinions expressed, and
the accuracy and completeness of the facts reported would always be protracted
and costly. Yet it would usually be inconclusive on the central questions.
Havighurst, supra note 18, at 362.
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reasons for rejecting this argument. First, it is not clear that making

these judgments is significantly more difficult than other antitrust decisions. 8 9 Moreover, the antitrust laws operate by deterrence as well as
judicial enforcement, so they may have benefits beyond the courtroom
that outweigh the occasional difficulties encountered in litigation. More
importantly, the accuracy of the speech need not be determined in some
absolute sense. It is, after all, only the speech's effects on the market
that are important, so it is only those effects that must be evaluated.
This can be done by investigating the effects the speech has on the
choices of the decision-makers at whom it is directed. The standard
would be a potential violation only if the speech leads consumers to
make different choices based on a standard's subjective evaluations than
they would have made with the available objective facts.
III.

PROPOSALS

As part II described, a deceptive or misleading medical standard is
anticompetitive to the extent that it makes patients forgo services that
they would have purchased with accurate information (or at least in the
absence of the misleading information). The market does not gain from
purchasing decisions made incorrectly. I propose, therefore, that professional societies be liable for economic injury suffered by their enactment of misleading standards. Although this may seem like a radical
proposal, it actually would result in liability in only a limited range of
cases. To establish a violation, a consumer or physician would be required
to satisfy the usual antitrust burdens of proof by showing that the society
possessed market power, that its standard was on balance anticompetitive
(i.e., misleading), and that he actually suffered injury as a result of the
society's standard. Not many society standards are so firmly expressed
and so publicly known that they will affect the demand for a particular
service, and presumably few of those are deceptive. Those that are,
however, are exactly the standards that are appropriate subjects of
concern.

189. For example, a typical rule of reason case under section 1 requires the assessment
of market power and the weighing of procompetitive and anticompetitive effects, both
tasks which are difficult and often inconclusive. That does not lead, however, to Professor
Havighurst's conclusion that the conduct challenged in such cases should be per se legal.
See id. at 362-63 n.82.
The dissent in Allied Tube made an analogous argument, objecting to the majority's
failure to define "workable boundaries" to the Noerr doctrine's distinction between political
and commercial speech. 486 U.S. at 513 (White, J., dissenting). The Court acknowledged
the dissent's criticism of "the uncertainty of such a particularized inquiry," but said that
blanket immunity was inappropriate and evaluation must rest on "the context and nature
of the activity." Id. at 507-08 n.10, 509.
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Standards can also influence the choices of consumers through their
effects on insurers. As Part I described, an insurer's unwillingness to
reimburse for a procedure is likely to discourage patients from seeking
it. Although such reimbursement decisions are generally the insurer's to
make as it chooses, they too can be improperly influenced by medical
societies. Therefore, I also propose that the societies be liable for anticompetitive harm that is effected in form through insurers but in fact
by the societies.
Both of these topics-the skewing by medical societies of decisions
by patients and third-party payers-are discussed below. A third section
discusses a topic mentioned briefly earlier. If a medical society is sufficiently concerned about encouraging or discouraging a particular practice, it can seek to have its position on that practice enacted into law.
Its efforts to do so will generally receive antitrust immunity under the
Noerr-Pennington doctrine. This then provides a legitimate, political
avenue for societies to impose the restrictions on patient choice that I
propose they should be forbidden to impose privately.
A.

Speech Directed at Patients

Under the antitrust rule of reason, a violation of Section 1 of the
Sherman Act occurs when a group with market power agrees on conduct
that is, on balance, anticompetitive. Because the actions of a medical
society are by their nature the subjects of agreement,' 90 proof that a

190. See supra note 7. Of course, an action taken by a society is actually effected
only by a subset of its members. The society is still liable for its actions, however. This
issue was considered by the Supreme Court in American Soc'y of Mechanical Eng'rs, Inc.
v. Hydrolevel Corp., 456 U.S. 556 (1982) (ASME), where it decided that normal agency
principles should apply.
In ASME, the anticompetitive activity was initiated by an executive of one of the
plaintiff Hydrolevel's competitors, McDonnell & Miller, Inc. (M&M). The executive was
vice-chairman of the ASME subcommittee responsible for standards governing two of the
companies' competing products. He and the chairman of the subcommittee drafted an
inquiry to the full committee questioning the safety of Hydrolevel's product. The inquiry
was sent to the ASME over the signature of M&M's president. Following standard
procedures, the ASME referred it back to the subcommittee, where the chairman "predictably" returned an unfavorable response. The chairman made the response "unofficial"
to avoid having to take it before the entire subcommittee, but it was signed by an employee
of the ASME and issued on ASME stationery. Id. at 560-64.
That the activity was anticompetitive was not at issue. The question on appeal was
the extent of the society's liability for its members' actions. The Court's strict approach
to trade associations is indicated by its willingness to find the society liable regardless of
whether it was an intended beneficiary of the anticompetitive practices: "The anticompetitive
practices of ASME's agents are repugnant to the antitrust laws even if the agents act
without any intent to aid ASME, and ASME should be encouraged to eliminate the

19931

MEDICAL SOCIETY ANTITRUST LIABILITY

medical standard violates the antitrust laws requires proof (1) that the
society enacting and promoting it possesses market power, (2) that the
standard's effects are anticompetitive, and (3) that the plaintiff suffered
injury. These tests are neither particularly difficult to apply to society
speech nor as likely as societies claim to chill desirable informationgenerating activity.
1. Market Power.-As described above, 191 the market in which professional societies operate is not the same one in which their members
sell their services. Medical societies, with regard to standards, operate
in the market for medical information. Therefore, one could evaluate
societies' market power by directly evaluating the effects of their actions
in that information market. For example, one could estimate market
power from market share by evaluating whether a society that issued a
statement regarding a particular service provided a large fraction of the
information available regarding the subject of that standard. The problem
with this approach, though, is that a society could provide all of the
information regarding a service, and it could even be believed, 192 but it
still might not affect the demand for the service. For example, the price
of a service could be so low, and its dangers, even as presented by a
society discouraging it, so minimal, that consumers would choose to
purchase it anyway. The information market, though it has the potential
to affect the medical services market, does not necessarily do so.
Therefore, a society's market power should be examined in the market
where the effects of its statements are ultimately felt, the market for
medical services. 193 In this market, there must be proof a society standard
affected demand for a service. This approach, the proof of market power
by market effects, was the one adopted by the Supreme Court in the
anticompetitive practices of all its agents acting with apparent authority .... " Id. at 574.
The parallel to professional societies is clear: regardless of whether the society itself
benefits, or the benefits accrue only to some of its members, the society can be held
liable for its anticompetitive acts.
191. See supra section II.B.
192. That a society provides a large proportion of the information regarding a
service does not, by itself, establish that it has market power, only that it has market
share. But if the society's statements are accepted, so that it actually influences opinions
regarding the service, it has market power (in the market for information regarding that
service). It must be remembered, though, that it is not anticompetitive effect in the
information market that is of concern. A distortion of consumers' views regarding medical
services is only significant (in the view of antitrust law) if it affects purchasing decisions
for those services. Therefore, it is only if power in the information market is "leveraged"
into the service market that there is anticompetitive harm. See supra note 121 and
accompanying text.
193. Of course, a society presumably only issues and publicizes a standard because
it believes that it has the power to affect demand for its services. See supra sections I.B
& II.B.
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only professional society case in which it examined market power,'9
FTC v. Indiana Federation of Dentists.1 95 That case challenged the
federation's rule prohibiting members from providing patients' x-rays to
insurers for evaluation of the services that the members provided. The
federation claimed that it lacked market power to enforce its rule.
However, the Court noted the FTC's finding that the federation's restrictions were adhered to by its members, and it said those effects were
"legally sufficient to support a finding that the challenged restraint was
unreasonable."' 96 Since a finding of market power is generally a question
of fact, the Court did not decide the question, but the discussion indicated
that the Court believed the federation had such power. 19
In a professional standard case the effects at issue are the reduction
(or increase) in demand for a particular service as a result of the standard.
Therefore, the plaintiff has the burden of showing that the standard
had sufficient market power to influence potential consumers' decisions
regarding the services. There are at least two ways of making this showing.
Following Indiana Federation of Dentists, the plaintiff could show that
the issuance of the standard was followed by a reduction in demand
for the service. The plaintiffs in Schachar alleged such a reduction, and
the Seventh Circuit apparently acknowledged that it occurred, stating
that "[s]peech informed, hence affected, demand for radial keratotomy."1 9 8 Under those circumstances, market power would be established,
though it would remain to be shown that the power had an anticompetitive
effect.
Another means of showing market power would be to offer the
testimony of specific patients who were themselves influenced not to
purchase the services in question. This was the approach taken, though
not explicitly, by the plaintiff in Koefoot, who provided an affidavit
stating that potential patients had declined to use him as a surgeon
because of the allegations of unethical surgery. 99 Proving market power

194. The issue of market power has not appeared in most professional society cases
heard by the Supreme Court because those cases have generally involved price restrictions.
In price cases, the Court has focused on the agreement among the members, and has
generally found a per se violation without making a specific finding of market power.
See, e.g., Arizona v. Maricopa County Medical Soc'y, 457 U.S. 332, 348 (1982).
195. 476 U.S. 447 (1986).
196. Id.at 461.
197. Id. at 460 ("The Commission found that ...Federation dentists constituted
heavy majorities of the practicing dentists and that as a result of the efforts of the
Federation, insurers in those areas were, over a period of years, actually unable to obtain
compliance with their requests for submission of x rays").
198. Schachar v. American Academy of Ophthalmology, Inc., 870 F.2d 397, 399400 (7th Cir. 1989).
199. See supra text accompanying notes 54-55. Dr. Koefoot's affidavit reported the
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in this manner is analogous to the approach in tying cases, where actual
influence over purchasing decisions can show market power.20° Although
the testimony of a "handful" of patients is not sufficient, 20 1 the plaintiff
need not show that every buyer was affected. In Fortner Enterprises,
Inc. v. United States Steel Corp.,202 the Supreme Court said that in the
tying context "sufficient economic power" is present "whenever the
seller can exert some power over some of the buyers in the market,
even if his power is not complete over them and over all other buyers
in the market." 203 It must be remembered, though, that the power over
buyers must actually come from the seller. If particular buyers, for their
own reasons, find the seller's product uniquely attractive, and therefore
feel compelled to purchase it, that does not show market power. For
that reason, liability in Fortner was rejected by the Court. Despite
testimony from buyers that they were coerced, there was nothing that
indicated that the defendant had any special advantage that allowed it
to force customers to accept its products. 2°4 The Court contrasted the
deficiency in proof in Fortner with the situation in Northern Pacific

statements made to him by patients, so the statements were hearsay. However, such
statements are admissible under the state-of-mind exception to the hearsay rule. Fed. R.
Evid. 803(3); see Hydrolevel Corp. v. American Soc'y of Mechanical Eng'rs, Inc., 635
F.2d 118, 128 ("'Statements of a customer as to his reasons for not dealing with a supplier
are admissible for this limited purpose. .

. ."')

(quoting Herman Schwabe, Inc. v. United

Shoe Machinery Corp., 297 F.2d 906, 914 (2d Cir. 1962), cert. denied, 369 U.S. 865
(1962) (citations and footnote omitted)), aff'd, 456 U.S. 556, cert. denied, 456 U.S. 989
(1982); see also JACK B. WErNsTnm; & MARGARET A. BERGER, WfINSTEN'S EVIDENCE
803(3)[03] (1992) ("The declarant's state of mind may be an issue in a wide variety of
contexts. Statements may be admitted, for example, to show . . . a customer's reason for
refusing to deal with a supplier ...." (footnote omitted)). In any event, Dr. Koefoot's
affidavit was submitted only in opposing summary judgment; he could presumably have
offered the patients' testimony directly at trial.
200. -See, e.g., Eastman Kodak Co. v. Image Technical Servs., Inc., 112 S.Ct.
2072, 2080 (1992) ("Market power is the power 'to force a purchaser to do something
that he would not do in a competitive market."') (quoting Jefferson Parish Hosp. Dist.
No. 2 v. Hyde, 466 U.S. 2, 14 (1984)); see also HERBERT HOVENCAmIp, ECoNomCs AND
FEDERAL ANTITRuST LAW § 8.10 (1985) ("[M]arket power is a necessary condition for
inefficient coercion .... ).

201. See, e.g., Grappone, Inc. v. Subaru of New England, Inc., 858 F.2d 792, 79497 (1st Cir. 1988).
202. 394 U.S. 495 (1965).
203. Id. at 502-03.
204. The defendant agreed to provide credit to the plaintiff for the purchase and
development of land, but only if the plaintiff would agree to purchase prefabricated homes
from the defendant. Although the credit terms offered by the defendant were apparently
not available elsewhere, the Court said that in the absence of evidence that the defendant
had any cost advantage in providing the credit, mere "uniqueness" of the credit arrangements would not provide economic power over buyers. See United States Steel Corp. v.
Fortner Enterprises, Inc., 429 U.S. 610, 617-22 (1977).
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Railway Co. v. United States,20 5 where it said not only that "[t]he very
existence of [the] host of tying arrangements [was] itself compelling
evidence of the defendant's great power," but that the defendant "possessed substantial economic power by virtue of its extensive landholdings.1 206 The point of this distinction is that it is not sufficient to show
the simple fact of conformity to the seller's wishes; there must also be
some reason to think that the conformity was caused by the power of
the defendant. In this respect, the case of professional societies is more
akin to Northern Pacific than to Fortner, because the societies' large
numbers of members and general prestige lend them the ability to
27
influence patients. 0
2. Anticompetitive Effect.-Proof of market power demonstrates
that the defendant has the potential to impose anticompetitive effects,
but a violation occurs only when that potential is realized. As described
above, 2 8 a society standard is anticompetitive when it is misleading or
deceptive. Because it is market effects that are important, the test for
deception is not a metaphysical search for truth, but only a test of
effect on consumers' decision-making. The Supreme Court, in its commercial speech decisions, has indicated that empirical evidence of deception can be used to make this determination.2 Such evidence could,
for example, be produced by a consumer survey of the kind used in
trademark cases. The two kinds of cases are in this respect quite similar,
since both involve the alteration of consumer choices by deceptive market

205. 356 U.S. 1 (1958).
206. Id. at 7-8. The United States government had granted to the defendant approximately forty million acres of land along the defendant's railroad tracks. Some of
the land contained valuable timber or mineral rights. Over the years the defendant sold
or leased many of the holdings. Some of the sales and lease agreements required use of
the defendant's services to ship products produced on the land, as long as its rates were
no worse than those of competitors. Id. at 3. No doubt it was not just the extent of
the defendant's holdings that concerned the Court, but also the fact that its means of
acquisition could not be duplicated by competitors.
207. The district court in Schachar addressed specifically this point:
However, in a case such as this where the statements are made by a large and
highly respected professional organization, factors other than the mere persuasive
power of its arguments render its statements influential. The views of such an
organization specializing in a field about which the general public is generally
uninformed, especially where the views are publically disseminated to potential
patients and third party payers, acquire significantly more weight and thus have
a more coercive effect than would the views of individuals.
Schachar v. American Academy of Ophthalmology, Inc., 1988-1 Trade Cases (CCH)
67,986, at 58,052 (N.D. Ill.).
208. See supra section II.C.
209. See Peel v. Attorney Registration and Disciplinary Comm'n of Illinois, 496
U.S. 91, 108 (1990) (plurality opinion).
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information. 210 Surveys to determine whether consumers have in fact

been deceived have long been admissible in this context, 21 l and similar
surveys could be conducted to determine whether statements by medical

societies mislead consumers or potential consumers of medical services.
For example, a society pronouncement regarding the safety of a procedure
could be tested to determine whether it conveyed accurate information
about the procedure's dangers. If the pronouncement under- or over-

stated the dangers, either in frequency or in character, it would be
anticompetitive. 212 Or, more to the point, a survey could be conducted
to determine whether a society statement has the same effect on a
consumer's likelihood of purchasing a 213service as does the objective
information available at the same time.
One possible concern is that the evaluation of professional services,
unlike that of trademarks, can change over time. A procedure once
thought unsafe may later appear to be safe, and vice versa. It might

therefore seem that to subject a society to liability for standards later
found to be misleading is overly restrictive. However, the Court has
noted that in the commercial arena, unlike the political one, the danger

of overbroad restrictions is not a significant concern. 214 It is therefore
210. See Havighurst & King, supra note 4 (pt. 1), at 136-37 (comparing medical
credentials to trademarks).
211. See, e.g., Zippo Mfg. Co. v. Rogers Imports, Inc., 216 F. Supp. 670, 680-86
(S.D.N.Y. 1963); see also Handbook of Recommended Procedures for the Trial of Protracted Cases, 25 F.R.D. 351, 426-29 (1960).
212. For example, in Koefoot, the defendant, the American College of Surgeons
(ACS), promulgated its view that the practice of "itinerant surgery" was "unethical,"
and said that it should be avoided in order to provide the highest quality of patient care.
See supra section I.A. Potential patients hearing the ACS's statements presumably formed
opinions regarding the safety of the practice. Although it might be difficult to quantify
those opinions, the patients could be surveyed to determine whether they understood
itinerant surgery to be unsafe, either in general or as practiced by Dr. Koefoot. If so,
and if the ACS could point to no objective facts to back up its statements, those statements
would have had anticompetitive effect. (Recall that even if the statements were anticompetitive, there would be no antitrust violation unless the ACS had sufficient market power
to affect Dr. Koefoot's business. See supra text accompanying notes 191-207.).
213. This test focuses more directly on the anticompetitive harm that a deceptive
standard may cause. It also allows the test to include deception due to factors other than
the substantive evaluation in the standard. For example, in Clamp-AII Corp. v. Cast Iron
Soil Pipe Inst., 851 F.2d 478 (1st Cir. 1988), cert. denied, 488 U.S. 1007 (1989), discussed
in note 135 supra, the plaintiff's allegation was that a trade association's standard might
have misled consumers into thinking that the association was a "disinterested certifying
organization." Id. at 487. Deception of this type is as capable of causing anticompetitive
harm as is deception regarding particular services. The test in either case is whether the
standard distorts consumer choice.
214. See Bates v. State Bar of Arizona, 433 U.S. 350, 380 (1977) ("IT]he justification
for the application of overbreadth analysis applies weakly, if at all, in the ordinary
commercial context.").
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not too great a demand on societies that they ensure that they do not
mislead consumers. This is especially so because a society can avoid the
problem entirely by confining its pronouncements to objective facts. For
example, instead of issuing a statement that a medical procedure is
unsafe, it could simply report the results of a study without providing
a conclusive interpretation of those results.21 1 Interpretation of the results
is then left to the individual patient and her physician.
3. Damages.-Finally,a plaintiff must prove she was damaged. This

requires that she show a loss in demand for her services as a result of
the society action. The proof is likely to be closely related to the plaintiff's

proof of market power. Both require establishment of the same sort of
connection between the defendant's actions and those of patients. Indeed,
if the proof of market power were made through the testimony of
coerced individuals, the evidence would also establish damages if the
testifying individuals were potential patients of the plaintiff. However,
if market power were proved by demonstration of a overall reduction
in demand, the plaintiff would also be required to show that she would

have been selected as the provider of the forgone services. This would
require, for example, that the plaintiff show that she had the skills and
facilities available to provide the service.
Meeting these burdens of proof to establish an antitrust violation
for issuing a deceptive standard is sufficiently difficult to discourage
frivolous claims. To appreciate this, consider that the tests provide two

"safe harbors" through which professionals can avoid all liability. First,
a single physician can say whatever she likes, as can a group of physicians
without market power.216 It is only market power that raises what would

215. To some extent, this is the practice currently used in many instances. Medical
journals often publish an article reporting the quantitative results of a research study,
with the implications of those results examined in an accompanying editorial. This approach
was used, in fact, in reporting the results of the PERK study of radial keratotomy. See
George 0. Waring III et al., Results of the Prospective Evaluation of Radial Keratotomy
(PERK) Study 4 Years After Surgery for Myopia, 263 J. A.M.A. 1083 (1990); Perry S.
Binder, RadialKeratotomy in the 1990s and the PERK Study, 263 J. A.M.A. 1127 (1990).
216. See Wilk v. American Medical Ass'n, 719 F.2d 207, 226-27 (7th Cir. 1983)
("Clearly, an individual medical doctor is free to act on this belief [that chiropractic is
undesirable] by declining to associate with a particular chiropractor in the care of a
particular patient. It seems reasonable that two or three medical doctors, sharing this view
and working as a team in the care of a particular patient would be free to agree, and
to act on the agreement, to decline to associate with a particular chiropractor in the care
of that patient. The Sherman Act problem in the present case arises from the express
embodiment of this viewpoint in a formal set of ethical principles promulgated by a large
association of medical doctors, and by the alleged efforts of that association and kindred
associations to give effect to the exclusionary attitude in the setting of hospitals staffed
by medical doctors.").
There would no doubt be disputes regarding the status of particular statements. For
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otherwise be a breach of professional ethics or false advertising to a
subject of antitrust concern. 217 Second, even a society with market power
can freely issue statements of objective fact. That means, for example,
that it can publicize the results of research studies. It need only ensure
218
It
that it does not put a "spin" on the facts that misleads patients.

example, is a statement by the president of a medical society, in which she refers to her
position in the society, a statement by the individual or by the society? Is a statement
by an individual that he has contacted most of the members of a medical society and
that most of them agreed that a particular procedure is unsafe a statement of the society?
These are fact-specific questions that cannot be answered here. Presumably they would
be resolved by determining whether the statements were made with the apparent authority
of the society. This test was established by the Supreme Court in American Soc'y of
Mechanical Eng'rs, Inc. v. Hydrolevel Corp., 456 U.S. 556 (1982). See supra note 187.
217. Cf. Schachar v. American Academy of Ophthalmology, Inc., 870 F.2d 397,
400 (7th Cir. 1989) ("The Sherman Act is not a code of medical ethics or methodology ....

).

218. The staff of the Federal Trade Commission addressed precisely this problem
in a rule-making proceeding in 1978. The proposed rule included the following requirement:
A standard shall contain the following:
(a) a statement of its intended scope and use, including products and
product attributes intended to be covered by the standard;
(b) a disclosure of any products or product attributes not covered by the
standard that users of the standard would reasonably presume were covered;
(c) a disclosure of any serious risks or limitations associated with use of
products that conform to the standard, when such risks or limitations would
not be apparent to reasonable buyers; and
(d) a statement as to how persons voted on the standard if a list of persons
who participated in the development proceeding is printed with the standard.
BuAu OF CONSUMER PROTECTION, FEDERAL TRADE CoMMISSION, STANDARDS AND CERTIFICATION: PROPOSED RULE AND STAFF REPORT (1978). The staff stated that the purpose

of these provisions was "to guard against deception and misreliance . .. which might
occur in their absence and thereby to ensure informed use of standards." Id. (footnotes
omitted).
The rule was never enacted. In 1980, Congress passed the Federal Trade Commission
Improvements Act of 1980, one section of which removed the F.T.C.'s authority to
establish rules regarding unfair or deceptive acts or practices in the development of
standards. See Pub. L. No. 96-252, § 7, 94 Stat. 374, 376 (1980). Interestingly, the
committee report for this statute expressed the view that an F.T.C. rule was unnecessary
because a deceptive standard would constitute a violation of the Sherman Act: "Given
that the rule is largely directed toward antitrust problems and the existence of adequate
remedies under the antitrust laws, the Committee believes that there is insufficient justification for a rulemaking in this area." S. REP. No. 500, 96th Cong., 2d Sess. 19,
reprinted in 1980 U.S.C.C.A.N. 1102, 1120. The specific antitrust doctrine to which
Congress referred was the prohibition of group boycotts. Id. However, so long as a
standards organization does not include consumers among its members, its standard-setting
activities will not constitute a boycott. See supra note 131. Therefore, a challenge to a
standard based on its deceptive or misleading effects must proceed on a different theory,
such as the one described in this paper. It is important to note, however, that Congress,
in precluding the F.T.C.'s rule-making, did not intend to discourage any such challenges
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is that sort of subjective and deceptive assessment that this proposal
seeks to prevent by requiring that a society with market power use it
wisely.

219

B. Speech Directed at Third-Party Payers
The competitive effects of society standards on third-party payers
are both similar to and different from their effects on individual patients.
The fundamental concern is still influence over patient choices, but the
mechanism by which those choices are influenced is entirely different.
In this case, patients' choices are influenced not by the standard itself
but by the insurer's response to it. If the insurer declines to reimburse
for a procedure, the cost to the patient rises from zero (or a small
insurance copayment) to the full price of the service. The likely result
is that the patient will be discouraged from receiving the procedure. Of
course, in general, an insurer is free to decide whether to reimburse for
a given service, and can make its decision on whatever basis it chooses.
A danger arises, though, when the insurer's power to make that reimbursement decision is controlled by a group of competing suppliers,
such as a medical society. If a society provides the insurer with information that distorts its decisions, or if the insurer more directly defers
to the society in its reimbursement decisions, the result can be anticompetitive.
1. Market Power.-A medical insurer's decisions affect competition
in the market in which patients choose their medical services. The Supreme
2
Court considered this issue in Blue Shield of Virginia v. McCready,=
where the plaintiff's insurer had adopted a policy of reimbursing for
psychotherapy only if it was performed by a psychiatrist rather than a
psychologist. The plaintiff challenged the policy, which she alleged was
the result of a conspiracy between the insurer, Blue Shield, and psychiatrists. Blue Shield argued that, because its policy's most direct effect
was on the terms of its contract with the plaintiff's employer, the relevant
market was that in which employers chose group health plans, not the

to specific deceptive standards; it specifically stated that its action did "not preclude the
Commission from engaging in case-by-case activities in this area." S. REP. No. 500, 96th
Cong., 2d Sess. 19, reprinted in 1980 U.S.C.C.A.N. 1102, 1120.
219. The suggestion of Professor Havighurst that a society's acquisition of respect
and esteem-power in the information market-should not subject it to scrutiny is, needless
to say, contrary to this view. See Havighurst, supra note 18, at 362 ("To subject a
professional body to close judicial review solely on the basis of the influence it wields
might be seen as penalizing its success in establishing its credibility and earning the
confidence of independent decisionmakers."). Antitrust law is premised on obligations
imposed by the possession of market power.
220. 457 U.S. 465 (1982).
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one in which patients chose psychotherapy services. 21 The Court disagreed, noting that the challenged act was the denial of reimbursement,
which affected the individual, not her health plan. 222 The relevant market
was therefore that in which the effects of the denial of reimbursement
were felt, the market for medical services. As the Court observed, "the
goal of the competitors was to halt encroachment by psychologists into
a market that physicians and psychiatrists sought to preserve for themselves."m
Given, then, that insurers can affect the market for medical services,
how is it that medical societies influence insurers? As described above,n4
insurers often rely on evaluations by medical societies in making their
reimbursement decisions. One possibility, therefore, would be that discussed in the last section: the society could issue standards or statements
that mislead or deceive the insurer. However, the danger of deception
does not exist for insurers nearly to the extent that it does for consumers.
Insurers often have physicians on their staffs, or, if they do not, they
can afford to have doctors serve in an advisory role. Furthermore,
insurers, unlike patients, encounter the same procedure numerous times,
so they have more reason to incur the information costs of evaluating
the procedure themselves. Therefore, even if a society issues a standard
that misleads consumers, it is unlikely to mislead insurers.
The situation is different, however, if the insurer does not take an
active role in making its reimbursement decisions. It is possible for the
insurer just to defer to the conclusions reached by a medical society.
This was the situation alleged by the plaintiffs in Schachar, and the
district court accepted the possibility:
Defendants' evidence that some third party payers made their
decisions on whether radial keratotomy would be covered independent of defendants' statements merely highlights the presence of disputed facts. By this evidence defendants have shown
that while some third party payers may not have relied upon
defendants' statements, others may have relied in whole or in
part upon defendants' statements.?
When an insurer relies "in whole" on a medical society's statement,
the decisions it reaches are notits own, but the society's. 2 6 One might

221. Id. at 479-81.
222. Id. at 480.
223. Id. at 478-79.
224. See supra text accompanying notes 83-85.
225. Schachar v. American Academy of Ophthalmology, Inc., 1988-1 Trade Cases
(CCH)
67,986, at 58,051-52 n.4 (N.D. Ill.).
226. A similar phenomenon was considered in a different context by the court in
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therefore hold the society responsible for the anticompetitive effects of
decisions made in that manner. That would be unfair, however. Although
27
society members typically agree on statements issued by the society,2
they do not necessarily seek to have those statements acted upon by a
third-party payer. The insurer may adopt the society's views for any of
a variety of reasons of its own. It may, for example, seek any available
excuse not to reimburse so as to minimize its costs, it may believe that
it is appropriate to defer to the expertise of medical professionals, or
it may just prefer the administrative convenience and reduced cost of
relying on the work of others.
A medical society should be liable for the effects of the adoption
of its statements by insurers only if it sought that adoption. That was
the case in Schachar, where the medical societies sought to have their
decisions put into effect by insurers. 22s The societies there did not merely
say that radial keratotomy was as yet unproven. Instead, they issued
formal statements that the procedure was "experimental," choosing to
apply the specific label on which insurers and hospitals based their
decisions.229 They issued their statements with the explicit direction that
they be announced to "third party insurers and payers."' 30 Finally,
through the auspices of the Council of Medical Specialty Societies, they
represented radial keratotomy to health insurers as a procedure that
should not be routinely reimbursed.2 31 All of these actions show an active
attempt to persuade insurers to adopt the societies' decisions. To the
extent that the attempt was successful, the societies exercised the insurers'
power in the medical services market.
The question that remains is that of determining the degree of market
power that medical societies can obtain by this means. Blue Shield did
not specifically address the market power issue, because its focus was
on the nature of the potential competitive injury caused by the insurer's

George R. Whitten, Jr., Inc. v. Paddock Pool Builders, Inc., 508 F.2d 547 (1st Cir.
1974), cert. denied, 421 U.S. 1004 (1975). The plaintiff there alleged that the defendant
had restrained trade by influencing a state agency's specification regarding swimming-pool
recirculation systems. The court disagreed, stating that "the specifications were the product
of the judgment, not unduly influenced by [the defendant], of the pool consultant." Id.
at 556. The court appeared to be sympathetic to the view that control over the decisionmaking process could have been a Section 1 violation, see id. at 555-61, but because
"[the defendant] was not the operative cause of decision," there was no violation, id. at
559.
227. Even if not all of a society's members agree on a statement, the society is
still liable for its effects. See supra note 190.
228. See supra section I.B.
229. See supra text accompanying notes 72-86.
230. See supra note 67.
231. See supra text accompanying notes 79-82.
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reimbursement decisions. Nevertheless, the Court's reference in that case
to the insurer's "concerted refusal to reimburse under a [health insurance]
plan" 212 suggests that the Court viewed the market as one consisting
specifically of Blue Shield subscribers, the only group for which Blue
Shield had the power to make reimbursement decisions. Normally the
relevant market for antitrust purposes is not as narrow as the customers
of a single provider. However, the Court has recently accepted the
possibility of such a market in cases in which customers are "lockedin" to one provider. 3 The situation of insureds who are contractually
bound to their insurer is a quintessential example of lock-in, as the
Court observed in Blue Shield.2 4 Given a market defined in this way,
i.e., as the subscribers of a single insurer, a medical society that could
influence the insurer's decisions would unquestionably have market power,
because it would control the reimbursement policy for virtually all that
insurer's subscribers.
Even in a broader market, though, a medical society could still
acquire significant market power. Consider, for example, the broadest
plausible market, which would be the entire market for the medical
service at issue. A medical society would control that share of that
market defined by the percentage of customers covered by insurers whose
decisions it influences. Since in many areas there are large insurers (e.g.,
Blue Shield or popular HMOs) with appreciable market shares, to attain
a large market share a medical society would" need to persuade only a
few of those insurers. Market share in these circumstances would provide
market power, due to the entry barriers created by the established
relationships between current medical societies and insurers.215 Therefore,
a society could acquire a large degree of market power through its
influence over insurers.
2. Anticompetitive Effect.-To illustrate the inherent anticompetitive
potential that exists when medical societies have the power to make
reimbursement decisions, consider a scenario based on the facts of Blue
Shield. Assume that an insurer has decided that it will defer to the
judgment of the American Psychiatric Association (Association), as a

232. Blue Shield, 457 U.S. at 480.
233. See Eastman Kodak Co. v. Image Technical Servs., Inc., 112 S. Ct. 2072,
2087 (1992).
234. See Blue Shield, 457 U.S. at 480 n.17 ("Although her employer's decision to
purchase the Blue Shield plan for her benefit was in some sense a factor that contributed
independently to [plaintiff's] injury, her coverage under the Blue Shield plan may, at this
stage of the litigation, properly be accepted as a given .... ).
235. Recall the relationship discussed above between the Council of Medical Specialty
Societies and the Health Insurance Association of America. See supra text accompanying
notes 77-82.
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prominent and respected medical society, in deciding whether to reimburse
for psychotherapy services. Assume further that its intention to do so
is known to the Association. The Association then decides, in good faith
or otherwise, that psychotherapy services are only properly performed
by psychiatrists, not psychologists, and the insurer, accordingly, declines
to reimburse for psychotherapy provided by psychologists. Under these
circumstances, it is the Association that has exercised the decision-making
power of the insurer. Moreover, it has exercised that power in the market
for psychotherapy services, a market in which its members directly
6

compete.2
The anticompetitive effects in these circumstances are very great. If
an insurer will not pay for a service, the patient must, and the price
of services to the patient therefore rises from zero (or near zero) to the
full price of the service.2 7 Thus, from the point of view of the patient,

who makes the purchasing decisions in the market at issue, a denial of
reimbursement is in effect a fixing of price.2 8 Again, this is not a
problem as long as the insurer makes the decision (i.e., sets the price)
itself, for it individually is free to make any pricing arrangements it
chooses. If, however, it is the medical society that is actually making
the reimbursement decision, it engages in a horizontal price-fixing agree-

236. A medical society might argue in this situation that, because its services (in
providing information) are used only by the insurer, not its insureds, it is the insurance
company market that is relevant. This is analogous to the defendant's unsuccessful argument
in Blue Shield that the relevant market in that case was for group health plans, and it
fails for the same reason: the intended and actual effect of the society's action is the
denial of reimbursement to the individual insured patients. See supra text accompanying
notes 220-23.
237. See Blue Shield of Virginia v. McCready, 457 U.S. 465, 483 (1982) ("Those
[Blue Shield] subscribers were compelled to choose between visiting a psychologist and
forfeiting reimbursement, or receiving reimbursement by forgoing treatment by the practitioner of their choice ....
[Plaintiff] did not yield to Blue Shield's coercive pressure,
and bore Blue Shield's sanction in the form of an increase in the net cost of her
psychologist's services.").
238. The most plausible alternative way to look at the arrangement is as a refusal
by insurers to deal with practitioners offering the non-reimbursed service. However, this
analysis is not as accurate, because there is no unwillingness to deal with those practitioners;
there is just a refusal to pay for a particular service. In any event, a refusal to deal,
like a fLxing of price, would be an act by the medical society, not the insurer. Therefore,
it would be a concerted refusal to deal, or group boycott, which under these circumstances
would be treated as severely as price-fixing. See Northwest Wholesale Stationers, Inc. v.
Pacific Stationery and Printing Co., 472 U.S. 284, 294 (1985) (noting the Court's per se
treatment of cases involving joint efforts "to disadvantage competitors by 'either directly
denying or persuading or coercing suppliers or customers to deny relationships the competitors need in the competitive struggle' (quoting LAWRENCE ANTHONY SuLLrVAN, HANDBooK oF THE LAW OF ANTITRUST 261-62 (1977)).
0
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ment as a group of professionals competing in the market at issue. 239
The society should be liable for the effects of that agreement. 2 °
Although imposing liability for a group's solicitation of action implemented by a third party may seem severe, it is supported by a Supreme
Court decision from this past term. In FTC v. Ticor Title Insurance
Co.,

24

1

the defendants were a group of title insurance companies that

formed state-licensed rating bureaus to propose rates for their services

to state insurance offices.Y2 The rates were proposed as part of a socalled "negative option" system, under which rates became effective
unless the states rejected them. 243 The companies claimed that, because
these programs were authorized by the states, the price-fixing was immune
from the antitrust laws under the state-action doctrine, which exempts
certain government acts from antitrust liability. 244 The Court rejected
239. A possible objection to this analysis is that there is no agreement between the
society and the insurer. But the absence of that agreement is irrelevant. The relevant
agreement is among the members of the society, who agree regarding the service and then
impose that agreement on their competitors via the intermediary of the insurer. See Business
Electronics Corp. v. Sharp Electronics Corp., 485 U.S. 717, 730 n.4 (1988) ("[A] facially
vertical restraint imposed by a manufacturer only because it has been coerced by a
'horizontal cartel]' agreement among his distributors is in reality a horizontal restraint."
(interpreting ROBERT H. BoRK, THE ANTrrRUST PARADox: A PoLIcY AT WAR WITH ITSELF

288 (1978)).
The insurer's absence from the agreement does exempt it from liability, however.
This is true even if the insurer is in favor of the society's decision, and is willing to rely
on it. So long as it acts independently and does not agree with the society, it is not
liable. See Monsanto Co. v. Spray-Rite Serv. Corp., 465 U.S. 752, 768 (1984) ("The
correct standard is that there must be evidence that tends to exclude the possibility of
independent action .... .
240. In these circumstances, that would probably require something approaching a
rule of reason inquiry. Although a per se rule still exists against blatant price-fixing, the
Supreme Court has applied a test between the per se rule and the rule of reason when
the challenged agreement is not so straightforward. See National Collegiate Athletic Ass'n
v. Board of Regents, 468 U.S. 85, 104 n.26 (1984) ("inhere is often no bright line
separating per se from Rule of Reason analysis."); Broadcast Music, Inc. v. CBS, 441
U.S. 1 (1979). In the present case, because a medical society's actions persuading an
insurer to discontinue reimbursement could serve legitimate informational purposes as well
as illegitimate competitive ones, application of the per se rule would be inappropriate.
241. 112 S. Ct. 2169 (1992).
242. Id. at 2174.
243. Id.
244. The state action doctrine as originally established in Parker v. Brown, 317
U.S. 341 (1943), broadly exempted all actions of the states from antitrust liability. The
doctrine was based on the view that in enacting the antitrust laws Congress did not intend
to restrain the states, and on more general notions of federalism. Since its establishment,
the doctrine has been narrowed. It now requires that for state actions to be exempt they
must be "clearly articulated and affirmatively expressed as state policy" and "actively
supervised" by the state. California Retail Liquor Dealers Ass'n v. Midcal Aluminum,
Inc., 445 U.S. 97, 105 (1980) (quoting City of Lafayette v. Louisiana Power & Light
Co., 435 U.S. 389, 410 (1978) (plurality opinion)).
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immunity, stating that the negative option schemes did not provide the
"active supervision" by the states that is required by the doctrine. 245 It
described the reason for that requirement:
Its purpose is to determine whether the State has exercised
sufficient independent judgment and control so that the details
of the rates or prices have been established as a product of
deliberate state intervention, not simply by agreement among
private parties. Much as in causation inquiries, the analysis asks
whether the State has played a substantial role in determining
the specifics of the economic policy. The question is not how
well state regulation works but whether the anticompetitive scheme
is the State's own. 246
The parallels with the medical standard-setting in a case like Schacha,-2 7
are clear. In both situations a private group agreed on a restriction for
the market in which its members sold their services. In both, the group
proposed that restriction for adoption by a third party with power in
its members' market. In both, the third party adopted the restriction.
In Ticor, there was no meaningful review of the restriction; in Schachar,
none was shown. The Supreme Court determined that the defendants
in Ticor were liable for the effects of their actions. In Schachar, where
the society sought and received similar action, it should also be liable,
especially because the action was effected by a private entity, not the
state.
3. Damages.-Damages for an antitrust violation of this kind could
be claimed either by patients or by practitioners. The injury to patients,
as in Blue Shield, would be the cost of medical services for which they
were not reimbursed because a society succeeded in having a decision
not to reimburse enactedY5s The injury to practitioners would be the
loss of business caused by the non-reimbursement decision. 249 One could

245. Ticor, 112 S. Ct. at 2178-80.
246. Id. at 2177. See also Patrick v. Burget, 486 U.S. 94, 101 (1988) ("The active
supervision prong of the Midcal test requires that state officials have and exercise power
to review particular anticompetitive acts of private parties and disapprove those that fail
to accord with state policy. Absent such a program of supervision, there is no realistic
assurance that a private party's anticompetitive conduct promotes state policy, rather than
merely the party's individual interests.").
247. See supra section I.B.
248. See supra text accompanying notes 220-23.
249. As described above, the defendant in Blue Shield argued that the plantiff in
that case, a patient, did not have standing to bring the action. See supra text accompanying
notes 220-23. The defendant argued instead that the proper plaintiffs were the competing
practitioners (psychologists) who were harmed by its reimbursement decision. 457 U.S. at
478. The Supreme Court rejected the defendant's argument with regard to patients, but
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also imagine a claim of damages by the insurer itself. In a situation
like that in Blue Shield, if the insurer adopted the decision not to
reimburse for psychologists' services as a result of the actions of the
psychiatrists, the insurer might in the end pay more to reimburse psychotherapy services (if psychologists provide those services more cheaply).
The insurer might then have a colorable claim against the psychiatrists.
However, an insurer in this situation, claiming damages for what is, in
form if not in fact, its own act, is perhaps in an unsympathetic position. 2 0
Imposing liability on medical societies in the circumstances described
in this section may seem less justifiable than imposing it for the deception
of consumers. However, as in that context, the tests proposed here
provide easily reached safe harbors for the societies. The easiest is for
a society to refrain from soliciting particular reimbursement decisions
from insurers. Although the evaluation of a society's actions in this
respect will be a fact-specific inquiry, liability should normally be avoided
if the society avoided overt solicitation of insurer action like that in
Schachar. Alternatively, even if it solicits a particular decision, the society
need only ensure that the insurer actually gives serious consideration to
the decision and does not automatically enact it in response to the
society's solicitation. Neither of these approaches is particularly burdensome, as long as the society truly does not seek to impose its decisions
on the marketplace.
Notably, in this case, accuracy in the society's statements is not in
itself a defense because liability is based not on any objective validity
or invalidity of the society's reasons for its decision, but on the fact
that the reimbursement decision is not the society's to make. Paraphrasing
Ticor, "[t]he question is not how well [the insurer's] regulation works
but whether the anticompetitive scheme is the [insurer's] own."2'2 The
rationale is no different from that which guides more typical antitrust
cases: market participants are not permitted to agree on restraints on
the market, no matter how objectively reasonable those restraints may
2
appear to them.

it did not disagree with the defendant's view regarding practitioners. Instead, it made

clear that both patients and competitors could recover: "[Tihe remedy cannot reasonably
be restricted to those competitors whom the conspirators hoped to eliminate from the
market." Id. at 479 (footnote omitted).
250. Cf. Ticor, 112 S. Ct. at 2178 (noting that thirty-six states filed a brief as
amici curiae stating that broad state-action immunity for insurance companies operating
under the supervision of state insurance commissioners was not in the states' interests).
251.

112 S. Ct. at 2177. See supra text accompanying note 246.

252. See, e.g., United States v. Socony-Vacuum Oil Co., Inc., 310 U.S. 150, 22122 (1940) ("Any combination which tampers with price structures is engaged in an unlawful
activity. Even though the members of the price-fixing group were in no position to control
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Speech Directed at the Government

The preceding sections argued that professional societies should not
be permitted to control buying decisions in the markets in which the
societies operate. However, at times the anticompetitive danger of such
control may be outweighed by legitimate public health concerns. Unscrupulous medical practitioners sometimes promote treatments that are
either worthless or actually harmful. When that occurs, medical professionals, and medical societies, have a legitimate role to play in discouraging the practice of such "quack" treatments. Typically, that role
will take the form of disciplinary proceedings within the framework of
private membership or state licensing procedures. For example, a medical
society may enforce against its members the same prohibitions on professional deception that this paper advocates be applied to the societies
themselves.2 3 Sometimes, however, as when the offending practitioner
is not a member of the society, internal procedures are not effective.
In that case, a society must resort to other attempts to discourage
performance of the service it believes to be unsafe. It does, however,
have an avenue to do so that does not implicate the dangers of anti4
competitive collusion addressed in this Article.

the market, to the extent that they raised, lowered, or stabilized prices they would be
directly interfering with the free play of market forces... . Congress has not left with
us the determination of whether or not particular price-fixing schemes are wise or unwise,
healthy or destructive.... It has no more allowed genuine or fancied competitive abuse
as a legal justification for such schemes than it has the good intentions of the members
of the combination."); see also supra text accompanying notes 145-50.
253. See infra text accompanying notes 276-77.
254. One commentator has suggested that the public safety should be a defense to
an antitrust challenge of a standard. See Michael Goldenberg, Standards, Public Welfare
Defenses, and the Antitrust Laws, 42 Bus. LAw. 629 (1987). He states that "[a]standard
having potential anticompetitive effects should be upheld only when the standards organization can demonstrate that the standard is reasonably necessary to protect the public."
Id. at 650 (footnote omitted). Mr. Goldenberg's concern is with standards that effectively
exclude products from the market, id. at 632-33, 650-51, so his focus is narrower than
that of this Article, which includes standards and statements that discourage but do not
actually exclude products. Nevertheless, the specific test that he describes is a more lenient
one than that presented in this Article. To determine whether an exclusionary standard
is "reasonably necessary" for public safety, Mr. Goldenberg proposes the application of
eight criteria. Id. at 653-65. Four of these criteria define a more-or-less substantive test
for safety-related standards, and it is those four that will be considered here. (As to the
remaining factors, one, safety-relatedness, is basically a prerequisite for application of the
test at all. See id. at 653-55. Another, anticompetitive intent, is discussed only briefly
and is apparently included largely because it may cast light on the other factors. See id.
at 660. There are also two procedural factors, one requiring that a standard be applied
non-discriminatorily and the other demanding that the standard-setting organization's
procedures be reasonable. See id. at 657-58, 662-65. These two criteria are subject to the
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If a society believes that any of the services of its profession, or
related professions, are undesirable because of safety or other reasons,

objections to procedural protections that were discussed above. See supra text accompanying
notes 141-53.)
Two of the substantive criteria address the issue of information availability. One says
that a standard should not be permitted to pre-empt consumer choice when consumers
have, or should have, access to the relevant information for making that choice. 42 Bus.
LAW. at 655-56. The other says that a standard should not be permitted to exclude a
product if a less restrictive alternative to exclusion is available. The most plausible such
alternative, and the one on which Mr. Goldenberg focuses, is the provision of relevant
safety information to consumers. Id. at 656-57. Considering these two factors together
makes clear that the only circumstance in which an exclusionary standard would be
permissible is when an organization was justified in not merely informing consumers of
any danger in the product in question. Mr. Goldenberg touches on this issue and notes
that in some cases "consumers and public officials may be unable to obtain all information
about a product and even the attempt to obtain such information may be costly," so
that a product ban may be the more efficient approach. Id. at 649; see also id. at 63335. He does not, however, discuss how to determine when that is the case, so these
criteria of his test provide little real guidance.
The other two substantive criteria more directly address the reasonableness of standards. One requires that an exclusionary standard be based on objective evidence, and
Mr. Goldenberg states that "the evidence at a minimum needs to be substantial enough
to have convinced most consumers not to use the product, had they been aware of the
evidence." Id. at 658. Somewhat similar is the last factor, in which Mr. Goldenberg
proposes to use "knowledgeable and reputable purchasers or other industry members" as
proxies for "reasonable consumers" in their purchasing decisions, because "a standard
should not be considered reasonable if consumers, with knowledge, would decide to purchase
the excluded product." Id. at 661. If these consumer proxies would use the product, he
says, exclusion of it is likely to be unreasonable, id. at 661-62; though he does not say
so, presumably acquiescence by a consumer group in an exclusionary standard would be
evidence that the standard is reasonable. These tests bear a surface similarity to the test
described in this Article, which proposes treating a standard or statement issued by a
group with market power as anticompetitive if it is deceptive, as evaluated by a survey
of consumer perceptions. See supra text accompanying notes 208-15. However, the two
tests are actually very different. This Article proposes making a determination of whether
a statement conveys accurate information for consumers to use in making purchasing
decisions; it does not propose removing the decision from consumers. Mr. Goldenberg,
in contrast, proposes excluding a product if most consumers, or perhaps a consumer
representative, given the relevant information, would opt not to purchase it. In other
words, Mr. Goldenberg would allow the removal of a product from the market by a
majority of consumers, or by a consumer group. But the antitrust laws do not permit
the market to be pre-empted by a majority vote of consumers, any more than they allow
such an action by a majority of producers. The market works through the choices of all
consumers, not just a majority of them. Recall that the Supreme Court has said that "a
purchaser might conclude that his interest in quality-which may embrace the safety of
the end product-outweighs the advantages of achieving cost savings by pitting one
competitor against another." National Soc'y of Professional Eng'rs v. United States, 435
U.S. 679, 694 (1978). It is implicit in that statement that a purchaser instead might, and
should be permitted to, choose cost savings over the safety of the product. See supra
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so that they should not be available, it can attempt to persuade the

state to impose the restrictions it desires. 255 Activities petitioning the
government, even if for an anticompetitive purpose, are protected from
antitrust liability by the Noerr-Pennington doctrine. The foundations of
the doctrine were laid in Eastern RailroadPresidentsConference v. Noerr

Motor Freight, Inc.,2 6 where the Supreme Court held that the Sherman

Act does not prohibit an association's attempt to persuade the legislative

or executive branches2 7 to take actions restraining trade. 25 Even if a

group's motive in petitioning the government is to provide advantage
to itself and disadvantage to its competitors, legitimate petitioning activity
does not violate the Sherman Act. 259 The Noerr-Penningtondoctrine thus

provides a broad immunity from antitrust liability for actions to influence
public officials.

As described above,2

there are some limitations on permissible

speech under the Noerr-Pennington doctrine. To a large extent, these

restrict only the use of misrepresentation or fraud in less political forums
text accompanying notes 145-50. A group of market participants must not interfere with
that choice. Such a group can properly seek to exclude a product only through the public
avenues provided by the state-action and Noerr-Penningtondoctrines. See Allied Tube &
Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 501 (1988) ("'We may presume,
absent a showing to the contrary, that [a government] acts in the public interest. A private
party, on the other hand, may be presumed to be acting primarily on his or its own
behalf."') (quoting Hallie v. Eau Claire, 471 U.S. 34, 45 (1985) (interpolation in Allied
Tube)).
255. It is possible that some insurers' actions, and even perhaps some professional
societies' actions, might be immune from antitrust liability if directed by regulations of
a federal agency, such as HCFA's coverage guidelines. See generally 1 PHmLLP E. AREEDA
& DONALD F. TUmR, A~NrrRusT LAw

222-27 (1978). However, liability would still

attach for effects on privately insured patients.
256. 365 U.S. 127 (1961).
257. Noerr's basic holding was later extended to administrative and adjudicative
settings, albeit perhaps with more restrictions, in California Motor Transport Co. v.
Trucking Unlimited, 404 U.S. 508 (1972).
258. The Court supported its holding on two grounds. First, it said that since the
government has the power to restrain trade, the people should be able to make known
their wishes regarding such restraints. Noerr, 365 U.S. at 137. Second, it said that to
hold otherwise would raise constitutional questions of the right to petition, and that the
Court "cannot ... lightly impute to Congress an intent to invade [that right]." Id. at
137-38.
259. Id. at 138-39. The Court has since held, though, that legitimate petitioning
activity may be relevant for proof of the anticompetitive intent of other activities. United
Mine Workers of Am. v. Pennington, 381 U.S. 657 (1965). Evidence relating to government
petitioning may be admitted "if it tends reasonably to show the purpose and character
of the particular transactions under scrutiny." Id. at 670-71 n.3 (quoting FTC v. Cement
Institute, 333 U.S. 683, 705 (1948)) (citations omitted). Admission of such evidence is
subject only to the usual limitation that it be probative and not unduly prejudicial. Id.
260. See supra text accompanying notes 157-60.
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than the legislature, such as the courts and administrative agencies. 261
Although the Supreme Court in Allied Tube suggested that this limitation

might extend to legislative committees, 262 it has imposed no general

accuracy requirement in the legislative arena. The reason for its reluctance
is its view that Congress in the Sherman Act did not intend to regulate
political activities. 23 Nevertheless, it is clear that where a private petitioner
possesses the information advantages of a professional society, advantages
that may not be shared by any other party, speech intended by the
society to persuade the government presents many of the same dangers
as does (other) commercial speech. 2"
Therefore, several commentators have proposed that commercial

speech standards be applied to Noerr-Pennington immunity, either by
eliminating Noerr-Pennington immunity as an independent doctrine

5

or

261. California Motor Transport Co. v. Trucking Unlimited, 404 U.S. 508, 512-13
(1972).
262. Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 504 (1988).
263. Noerr, 365 U.S. at 140-41; see also California Motor Transport Co., 404 U.S.
at 512-13.
264. The informational advantages of professional societies present problems even
in the absence of any intent to deceive. See, e.g., ANTHONY DowNs, AN EcoNowc THEORY
OF DEMOCRACY 255 (1957):
Mhe cost of acquiring information and communicating opinions to government
determines the structure of political influence. Only those who can afford to
bear this cost are in a position to be influential.
A striking example of this fact is the failure of consumers-at-large to
exercise any cogent influence over government decisions affecting them. For
instance, legislators are notorious for writing tariff laws which favor a few
producers in each field at the expense of thousands of consumers. On the basis
of votes alone, this practice is hardly compatible with our central hypothesis
about government behavior. But once we introduce the cost of information, the
explanation springs full-armed from our theory. Each producer can afford to
bring great influence to bear upon that section of the tariff law affecting his
product. Conversely, few consumers can bring any influence to bear upon any
parts of the law, since each consumer's interests are spread over so many
products.
The possibility of deception is, a fortiori, of greater concern.
265. See Ernest Gellhorn, Another Perspective on Antitrust Immunity for Petitions
to Government, in THE PoUTncAL EcoNoKY OF REGULATION: PRIVATE INTERESTS IN THE
REGULATORY PRoCESs 89 (1984). Professor Gellhorn proposed what he called "a merger
of the developing doctrine of commercial speech under the first amendment with the
doctrine of immunity for petitions to government under the antitrust laws." Id. at 90
(footnote omitted). He referred to the similarities in function between the antitrust laws
in preserving an open private market with vigorous product competition and the first
amendment in maintaining an open political "market" with "competition in ideas and
interests." Id. at 91. The approach that he proposed was basically to apply traditional
first amendment tests of time, place, and manner to government regulations of speech
for antitrust purposes, though he would have also allowed more strict commercial speech
standards to be applied as they developed. Id.
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by applying it only where the speech is not commercial. 266 Both of these
approaches, however, are undesirable because it is unwise to base antitrust
immunity purely on the evolving commercial speech standard. It is not
impossible that the Supreme Court could decide that commercial speech
is not worthy of protection at all. 267 Even if that were to happen, NoerrPennington speech, because it is directed at the government, would still
have an undeniably political component that would remain worthy of
protection. Commercial entities should continue to be able to petition
for government action favorable to their competitive positions independent of any restrictions that may be imposed on their speech in the
marketplace.
I suggest, however, that professional societies should be liable for
intentional deception in their government petitioning. In CaliforniaMotor
Transport Co. v. Trucking Unlimited,26 the Supreme Court said that

practices such as perjury or patent fraud could be an abuse of governmental processes sufficient to remove them from Noerr-Pennington immunity. 269 The Court there limited this exception only to administration

266. See Natalie Abrams, Note, The Sham Exception to the Noerr-Pennington
Doctrine:A Commercial Speech Interpretation,49 BROOK. L. Rav. 573 (1983). The author
there suggested that "legislative petitioning be considered commercial speech if it (1)
involves the business of the entity, and (2) if effective, would result in an economic
benefit to the speaker." Id. at 596. She recognized, though, that this test could have
encompassed some speech that would have typically been thought of as political, not
commercial. Id. See also Central Hudson Gas & Elec. Corp. v. Public Serv. Comm'n of
N.Y., 447 U.S. 557, 563 n.5 (1980) ("[M]any, if not most, products may be tied to public
concerns with the environment, energy, economic policy, or individual health and safety.").
To meet this problem, she said that it could also be required that the speech be of the
character that the Court said in Virginia Board of Pharmacyjustified the lesser restriction
on commercial speech: that is, first, that it be easily verifiable by the speaker and, second,
that the speaker have a significant commercial motivation to make it so that he is less
likely to be deterred by regulation. Note, supra, at 596. See also supra note 164 and
accompanying text. But her proposed test was then no more than a restatement of the
second of the requirements of the Court. After all, if the speaker is strongly motivated
to make the speech for commercial reasons, it must concern his business and be to his
economic benefit. This is not to deny that businessmen and businesswomen might sometimes
make speech related to their businesses that is not to their benefit, but presumably the
Virginia Board of PharmacyCourt's concern for strong commercial motivation would not
be met in such a case. For similar views, see also James D. Hurwitz & Debra Simmons
Neveu, The Noerr Doctrine: Its Significance and CurrentInterpretation, in THE PorcAL
EcoNoMY OF REoULATION: PRrvATE INTERrSTs iN ma Rau.LAToxy PRocEss 33 (1984), and
James D. Hurwitz, Abuse of Governmental Processes, the First Amendment, and the
Boundaries of Noerr, 74 GEo. L.J. 65 (1985).
267. This possibility appears unlikely in light of the Court's most recent discussion
of the issue. See Cincinnati v. Discovery Network, Inc., 113 S. Ct. 1505 (1993).
268. 404 U.S. 508 (1972).
269. Id.at 512.
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or judicial processes. 270 However, at least for professionals, who possess
specialized knowledge that makes their statements difficult, if not impossible, for others, such as legislators, to evaluate, the fraud exception
to Noerr-Penningtonimmunity should be extended to the legislative arena.
Allied Tube apparently supported this view in its dicta to the effect that
misrepresentations to legislative committees would be impermissible. 27'
This restriction on immunity should, however, be confined to active
misrepresentations, as Allied Tube appears to contemplate. This would
allow societies to petition the government with statements that were
inaccurate at the time of the petitioning or were later found to be
misleading, so long as the societies were unaware of the inaccuracies.
Such a rule would provide sufficient protection to encourage professionals
to seek government action based on legitimate concerns of safety.
IV.

CONCLUSION

There is "no basis for believing that professionals act without regard
for their own economic interests and, therefore, no basis for antitrust
purposes of a broad distinction between 'professional' and 'business'
conduct. ' 27 2 If members of a non-professional business group with market
power joined together to make deceptive or misleading statements about
competitors' products, and consumers were in fact dissuaded from purchasing those products, or if the group through a third party was able
to raise the products' prices to consumers, the group would be subject
to antitrust liability. 273 There is no reason not to apply the same rule
to professional groups, especially since the specialized knowledge that
professionals possess makes it difficult for others to evaluate their statements.
The basic rationale animating the proposals in this paper is that a
professional group should not be able to distort the workings of the
market through its private decisions. 274 Restraints enacted by a private
society are "imposed by persons unaccountable to the public and without

270. Id.
271. Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492, 504 (1988).
272. Thomas E. Kauper, Antitrust and the Professions:An Overview, 52 ANTTRusT
L.J. 163, 172 (1983); see also Philip C. Kissam, Antitrust Law and ProfessionalBehavior,
62 Tax. L. Rav. 1, 11 (1983) ("[S]everal 'Chicago school' economists studying the

professions assume that professionals have the same profit-maximizing interests as people
in other businesses and that professional self-regulation, like any regulatory legislation, is
more likely to result from 'interest group' bargaining than from a principled consideration
of the public interest." (footnote omitted)).
273. As described in notes 121, 213 & 226 supra, several cases have, at least in
principle, accepted these damage theories in cases involving non-professional groups.
274. See supra text accompanying notes 145-50.
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official authority, many of whom have personal financial interests in
restraining competftion.'2 1 The other side of this rule is that a society
should be permitted to seek state-imposed restraints. By requiring the
organization to take that route, its proposed standards are made subject
to the scrutiny (such as it is) that results from any attempt to obtain

government action, and they are subject to question from other segments
of society. Standards established through this process are more likely

to benefit all of society, not just the profession.
The elimination of all but governmentally-adopted professional standards need not eliminate the traditional self-policing role of the professions. It would, however, shift its focus. Under this approach, a
professional association's self-policing activities would be confined to
the investigation of individual cases in which unprofessional activity is
alleged. It could, for example, enforce prohibitions against deceptive

practices by its members. 276 This would allow it to discipline members
who were misleading patients regarding the risks of procedures that the
society believed were dangerous, and would therefore obviate much of
the need for possibly deceptive speech by the society discouraging those
procedures. Furthermore, this sort of disciplinary proceeding would require specific evidence of a violation of professional standards, as well
as a process providing quasi-judicial procedural protections, so it would
eliminate much of the anticompetitive danger created by purely internal
society proceedings. 277

As to the undesirability of an association supporting sanctions against
its members, such a practice would seem to be an essential function of
a self-policing profession. Indeed, it is just the professions' failure to

275. Allied Tube & Conduit Corp., 486 U.S. at 502.
276. The right of medical societies to perform this function was upheld in American
Medical Ass'n v. F.T.C., 638 F.2d 443 (2d Cir. 1980), aff'd by an equally divided Court
per curiam, 455 U.S. 676 (1982). In that case, the American Medical Association (AMA)
and two local medical societies challenged an FTC cease and desist order that prohibited
them from effecting restraints on advertising, solicitation, and contracting by physicians.
The order allowed the AMA to enforce prohibitions on false and deceptive advertising
by its members, but the AMA contended that that exception afforded it insufficient
protection in case it initiated enforcement proceedings against advertising that was later
determined not to be deceptive. Id. at 452. In response, the court amended the order to
allow the AMA to "enforc[e] reasonable ethical guidelines governing the conduct of its
members with respect to representations, including unsubstantiated representations, that
[the AMA] reasonably believes would be false or deceptive within the meaning of Section
5 of the Federal Trade Commission Act." Id. (emphasis in original). This standard gives
medical societies considerable freedom to control attempts by their members to promote
unproven or dangerous procedures.
277. Id. at 450 (noting that the FTC's Order "require[d] AMA in any proceeding
involving violations of its ethical standards to provide (A) reasonable notice, (B) a hearing,
and (C) written findings and conclusions.").
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perform this function, the tendency of professions to "protect their
own," that has caused much of their loss of public trust and esteem.
In addition, any argument by a profession that such a practice is
undesirable for professional morale is too self-serving to be given much
credence. On the contrary, it should greatly benefit professional morale
to ensure that the standards of the profession are maintained by sanctioning those who do not meet them.
These changes to current rules would therefore result in a somewhat
different role for professional societies. Instead of functioning as quasilegislatures deciding how their professions should be practiced, as they
often do now, they would serve more as information clearinghouses, 27
and decisions regarding particular practices would be made by individual
professionals. 279 The result would be a much more open professional
environment, with greater opportunity for procompetitive development
of new techniques and," consequently, better long-range health for the
professions.

278. Nothing in this Article prevents professional societies from communicating
objectively supported information to the public or to insurers. See supra sections II.C &

II.D.
279. See Clark C. Havighurst, ProfessionalRestraints on Innovation in Health Care
Financing, 1978 DutE L.J. 303, 346-47 n.184 (The author "would permit professional
groups to emphasize positive professional values but would encourage courts to regard

with suspicion collective actions to denigrate alternative approaches or to focus professional
disapproval on a specific competitor or would-be innovator.").

